Manuel R. Teixeira was born in Porto in 1967 and received his medical degree from the School of Medicine and Biomedical Sciences (ICBAS) of the University of Porto (UP) in 1992. He obtained his PhD (Dr Med) degree in Medicine (Medical Genetics) at the University of Oslo, Norway, after performing his doctoral studies in the field of cytogenetic heterogeneity of breast cancer at the Department of Medical Genetics of Odense University Hospital in 1993-1994 and then at the Department of Genetics at the Institute for Cancer Research, The Norwegian Radium Hospital (now part of Oslo University Hospital) in 1994-1997, under the supervision of Prof. Sverre Heim. He then obtained a postoctoral research position from the Norwegian Cancer Society for 1998-2000 to work on molecular cytogenetic methods to gather prognostic information from diagnostic biopsies of prostate cancer patients at the Oslo University Hospital. In February 2001 Manuel R. Teixeira was hired as Assistant Researcher at the Portuguese Oncology Institute of Porto (IPO Porto) and was appointed Coordinating Researcher in 2008. He is the Head of the Department of Genetics of this institution since May 2001, where he was responsible for the implementation the areas of molecular cytogenetics diagnosis of hematological diseases and conventional and molecular cytogenetic diagnosis of soft tissue tumors and for genetic counseling of families with inherited cancer predisposition (from June 2004 to 2021). In September 2003 he led the implementation of the IPO Porto Research Center (CI-IPOP), being appointed its Director from 2003 to 2021, in parallel with his diagnostic activities at the Department of Genetics. The CI-IPOP has been recognized as a Research and Development Unit since 2004 by the Portuguese Science and Technology Foundation and was classified as Excellent in the last international evaluation. Besides his main appointment at IPO Porto, Manuel R. Teixeira is a Guest Full Professor at the School of Medicine and Biological Sciences (ICBAS) of the University of Porto, where he is responsible for the curricular unit of Medical Genetics of the integrated master degree in Medicine, as well as of the curricular units of Oncobiology (MSc degree in Oncology), Genes and Cancer (PhD degree in Pathology and Molecular Genetics), and Molecular Cytogenetics (MSc and PhD degrees in Molecular Medicine and Oncology). His research interests are pursued as the coordinator of the Cancer Genetics Group of CI-IPOP, a multidisciplinary research group that includes medical doctors, pharmacists, biochemists and biologists, all specialized in cancer genetics. His research group aims to study the interplay between inherited cancer predisposition and the pattern of acquired genetic alterations that give rise to cancer, in order to understand the mechanisms of tumor initiation and progression and their role in therapy response and resistance. In fact, the fields of germline and somatic genetics are progressively more interconnected, as exemplified by shared mutation signatures that might have similar predictive value for targeted cancer therapy. Over the years his group has discovered several novel gene fusions in different malignant diseases, as well as several founder germline variants associated with cancer predisposition. Recently, his group has discovered PRUNE2 as a novel gene involved in prostate cancer predisposition, especially for early-onset and/or familial disease. He has authored or co-authored more than 330 publications in international peer-reviewed journals and several book chapters and his publications were cited more than 14.000 times (H-index: 61). The updated publication list can be found here: http://publicationslist.org/manuel.r.teixeira

Personal identification

Full name
Manuel António Rodrigues Teixeira

Citation names

  • Teixeira, Manuel R.

Author identifiers

Ciência ID
Researcher Id
Scopus Author Id

Email addresses

  • manuel.teixeira@ipoporto.min-saude.pt (Professional)
  • mateixeira@icbas.up.pt (Professional)


  • 225084000 Ext.: 7916 (Professional)


  • Dpt. Laboratory Genetics, IPO Porto, Rua Dr. António Bernardino Almeida, 4200-072, Porto, Porto, Portugal (Professional)


Knowledge fields

  • Medical and Health Sciences - Basic Medicine - Human Genetics


Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Norwegian Upper intermediate (B2) Advanced (C1) Upper intermediate (B2) Advanced (C1) Advanced (C1)
Degree Classification
Habilitado para funções de coordenação científica (Título de Habilitação de Coordenação Científica)
Major in Oncobiology (Cancer Genetics)
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
1994 - 1997
Doctor Medicinae (Doctor of Philosophy)
Major in Medicine (Medical Genetics)
Universitetet i Oslo Det medisinske fakultet, Norway
"Intra- and intertumor cytogenetic heterogeneity in breast cancer" (THESIS/DISSERTATION)
1986 - 1992
Medicina (Licenciatura)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal


Host institution
2008/11/26 - Current Coordinating Researcher (Research) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2001 - 2008 Auxiliary Researcher (Research) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
1998 - 2000 Postdoc (Research) Oslo Universitetssykehus Institutt for kreftforskning, Norway

Teaching in Higher Education

Host institution
2009 - Current Invited Full Professor (University Teacher) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2007 - 2009 Invited Associate Professor (University Teacher) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2002 - 2007 Invited Assistant Professor (University Teacher) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Other Careers

Host institution
1993 - 1993 Interno (Médica) Centro Hospitalar Universitário do Porto EPE, Portugal

Positions / Appointments

Host institution
2001 - Current Organic Unit Director Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2003 - 2021 Organic Unit Director Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal


Designation Funders
2019 - 2024 Inherited predisposition to gastric cancer: novel susceptibility genes and a minimally invasive screening strategy in germline mutation carriers
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2018 - 2023 Germline mutations in genes involved in the chromosome segregation machinery associated with inherited prostate cancer predisposition
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2017 - 2023 Recurrent germline mutations in patients with early-onset and/or familial prostate cancer
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2016 - 2021 Detection of cancer specific genetic alterations in circulating free tumor DNA as a tool for early cancer diagnosis and follow up in Lynch syndrome patients
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2011 - 2014 Hereditary predisposition to prostate cancer
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2011 - 2014 Characterization of membrane receptors differentially overexpressed in prostate carcinomas with and without ETS fusion genes
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2011 - 2014 Phenotypic and genotypic heterogeneity of hereditary breast and ovarian cancer
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2010 - 2013 Spectrum of somatic mutations in tumors arising in different large bowel locations in patients with hereditary predisposition to colorectal cancer
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2009 - 2012 Characterization of fusion oncogenes involving the ETS family of transcription factors and their role as diagnostic and prognostic markers in prostate cancer
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2007 - 2010 Fusion oncogenes involving the ETS family of transcription factors in prostate cancer: target genes and clinical applications
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2007 - 2010 Expression changes of the ETS family of transcription factors associated with chromosome rearrangements in breast cancer
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2007 - 2010 Gene targets of 5q copy number gain and mechanisms of resistance to targeted therapy in clear cell renal cell cancer
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2006 - 2009 Microarray analyses of prostate cancer: integrating genome-wide DNA copy number changes and RNA expression levels to uncover molecular markers of disease progression
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia


Designation Funders
2017 - Current Validation of liquid biopsies for predictive biomarker testing, therapy response monitoring, and resistance mechanism identification in cancer patients
CI-IPOP 54-2017
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação
2016 - Current Detection of cancer specific genetic alterations in circulating free tumor DNA as a tool for early cancer diagnosis and follow up in Lynch syndrome patients
CI-IPOP 36-2016
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação
2016 - Current Identification of somatic and germline mutations in circulating tumor DNA in ovarian cancer patients and in germline BRCA1/BRCA2 mutation carriers undergoing cancer screening
CI-IPOP 35-2016
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação
2015 - Current Inherited predisposition to prostate cancer
CI-IPOP 24-2015
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação
2021/01/01 - 2025/12/31 Health Research Network: From Lab to Community Health
Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Universidade do Algarve, Portugal

Universidade do Porto Faculdade de Ciências, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Universidade da Madeira, Portugal

Universidade de Lisboa Centro Cardiovascular da Universidade de Lisboa, Portugal

Universidade de Aveiro, Portugal

Centro de Investigação em Tecnologias e Serviços de Saúde, Portugal

Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal

Escola Superior de Enfermagem do Porto, Portugal

Universidade do Porto Faculdade de Medicina, Portugal

Universidade NOVA de Lisboa, Portugal
Fundação para a Ciência e a Tecnologia
2017 - 2024 Identification of germline mutations by gene-panel next generation sequencing in familial tubular and mixed tubular-diffuse gastric cancer
CI-IPOP 56-2017
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação
2020/01/01 - 2023/12/31 IPO Porto Research Center
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
2020/01/01 - 2023/12/31 IPO Porto Research Center
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
2021/06/01 - 2023/11/30 The Porto Comprehensive Cancer Center
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Instituto Nacional de Engenharia Biomédica, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Fundação para a Ciência e a Tecnologia
2018/07/26 - 2021/11/25 The role of chromosome segregation machinery defects in genetic predisposition to prostate cancer.
Co-Principal Investigator (Co-PI)
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Instituto de Biologia Molecular e Celular, Portugal

Rede de Química e Tecnologia Laboratório Associado para a Química Verde, Portugal
Fundação para a Ciência e a Tecnologia
2019/01/01 - 2019/12/31 Portuguese Oncology Institute - Porto Research Center
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
2016/07/01 - 2019/07/01 Inherited predisposition to prostate cancer: finding the missing heritability by combining exome sequencing and haplotype analyses in a population with strong founder effects
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2015/01/01 - 2018/12/31 Portuguese Oncology Institute - Porto Research Center
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
2014/01/01 - 2014/12/31 Strategic Project - UI 776 - 2014
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
2011 - 2014 Identification of novel fusion genes originated by chromosome rearrangements in hematological malignancies
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte
2013/01/01 - 2013/12/31 Incentive - UI 776 - 2013
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
2011/01/01 - 2013/12/31 Strategic Project - UI 776 - 2011-2012
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
2009 - 2012 Genetic study of Common Hereditary Bowel Cancers in Hispania and the Americas (CHIBCHA)
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
European Union
2008 - 2011 Fusion oncogenes involving the ETS family of transcription factors in prostate cancer: target genes and clinical applications
CI-IPOP 9-2008
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação
2007/09 - 2010/08 Characterization of fusion genes involving the ETS family of transcription factors and their role as diagnostic and prognostic markers in prostate cancer
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2006 - 2010 Identification and characterization of novel MLL partner fusion genes in acute leukemia patients
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Associação Portuguesa Contra a Leucemia
2005/07/01 - 2008/06/30 In mismatch repair deficiency colorectal cancer are BRAF and KRAS new prognostic and therapeutic tools?
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
2005/04 - 2008/03 Identification of target genes of genomic deletions and amplifications common to breast and prostate cancer
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2002 - 2006 Diagnostic and prognostic value of cytogenetic and molecular genetic analyses of sextant biopsies from prostate cancer suspects
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
2002 - 2004 Comparative genomic hybridization analysis of sextant biopsies from prostate cancer suspects
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Ministério da Saúde
1995/01/01 - 1997/12/31 Cytogenetic Heterogeneity in Breast Cancer
PhD Student Fellow
Fundação para a Ciência e a Tecnologia


Book chapter
  1. Teixeira, M.R.; Heim, S.. "Tumors of the male genital organs". In Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells, edited by Sverre Heim, Felix Mitelman. New York, United States: Wiley-Liss, 2015.
  2. Teixeira, M.R.; Pandis, N.; Heim, S.. "Tumors of the breast". In Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells. New York, United States: Wiley-Liss, 2015.
  3. Teixeira, M.R.; Heim, S.. "Cytogenetic Analysis of Tumor Clonality". In Advances in Cancer Research, 127-149. Academic Press Inc., 2011.
    Published • 10.1016/B978-0-12-387688-1.00005-3
  4. Teixeira, M.R.; Pandis, N.; Heim, S.. "Tumors of the Breast". In Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells, edited by Sverre Heim, Felix Mitelman. New York, United States: Wiley-Liss, 2010.
    Published • 10.1002/9781118010136.ch15
  5. Teixeira, M.R.; Heim, S.. "Tumors of the Male Genital Organs". In Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells, edited by Sverre Heim, Felix Mitelman. New York, United States: Wiley-Liss, 2010.
    Published • 10.1002/9781118010136.ch17
  6. Ribeiro, F. R.; Skotheim, R. I.; Henrique, R.; Teixeira, M. R.. Corresponding author: Teixeira, M. R.. "Array-Based Comparative Genomic Hybridization in Prostate Cancer: Research and Clinical Applications". In General Methods and Overviews, Lung Carcinoma and Prostate Carcinoma, 415-429. United States: Springer Netherlands, 2008.
    Published • 10.1007/978-1-4020-8442-3_30
  7. Teixeira, M. R.; Pandis, N.; Heim, S.. Corresponding author: Heim, S.. "Genome-wide analysis of breast cancer by chromosome banding and comparative genomic hybridization.". In Focus on Breast Cancer Research, 37-66. New York, United States: Nova Biomedical Books, 2004.
  8. Wilkinson, E.J.; Teixeira, M.R.. "Epithelial tumors of the vulva.". In Pathology and Genetics of Tumours of the Breast and Female Genital Organs, edited by P Kleihues; WK Cavenee. Lyon, France: WHO Lyon: IARCPress., 2003.
  9. Kempson, R.L.; Teixeira, M.R.; Hendrickson, M.R.. "Soft tissue tumors of the vulva". In Pathology and Genetics of Tumours of the Breast and Female Genital Organs, edited by P Kleihues; WK Cavenee. Lyon: WHO Lyon: IARCPress., 2003.
  10. Wilkinson, E.J.; Teixeira, M.R.. "Melanocytic tumors of the vulva". In Pathology and Genetics of Tumours of the Breast and Female Genital Organs, edited by P Kleihues; WK Cavenee. Lyon, France: WHO Lyon: IARCPress., 2003.
  11. Teixeira, M.R.; Heim, S.. "Clonal evolution of neoplastic cell populations: lessons from solid tumor cytogenetics". In DNA Alterations in Cancer: Genetic and Epigenetic Changes. Natick, MA: Eaton Publishing, 2000.
  12. Heim, S.; Teixeira, M.R.; Pandis, N.. "Cytogenetic Approaches to Breast Cancer". In Breast Cancer, 373-388. Humana Press, 1999.
    Published • 10.1007/978-1-59259-456-6_17
Conference poster
  1. Cruz, Pedro; Meneses, Olga; Ramos, Raquel; Brandão, Andreia; Veiga, Isabel; Rocha, Patricia; Henrique, Rui; et al. Corresponding author: Paulo, Paula. "Eficácia de anti-EGFR em cancro colorretal metastizado é aumentada pela sobreexpressão de EGFR ou ETV4 e reduzida pela de ETV5 ou ETV1". Paper presented in 3ª Edição do Concurso de Pósteres Científicos Revolution Poster Awards by Pierre Fabre, 2023.
  2. Paiva, Elsa; Orr, Bernard; Teixeira, Manuel R.; Paulo, Paula. Corresponding author: Paulo, Paula. "Molecular subtypes of prostate carcinomas may identify patients eligible for combined anti-EGFR/STAT3 therapy". Paper presented in 1st Young Researcher's Day, 2023.
  3. Ramos, Raquel Almeida; Brandão, Andreia; Cruz, Pedro; Meneses, Olga; Veiga, Isabel; Rocha, Patricia; Henrique, Rui; et al. Corresponding author: Paulo, Paula. "PEA3 transcription factors are prognostic biomarkers of response to anti-EGFR therapy in metastatic colorectal cancer". Paper presented in 1st Young Researcher's Day, 2023.
  4. Meneses, Olga; Cruz, Pedro; Ramos, Raquel; Brandão, Andreia; Veiga, Isabel; Rocha, Patricia; Henrique, Rui; et al. Corresponding author: Paulo, Paula. "Determinantes moleculares da eficácia terapêutica anti-EGFR no cancro colorretal metastizado.". Paper presented in 20º Congresso Nacional de Oncologia, 2023.
  5. Silva, Maria P.; Ferreira, Luisa T; Bras, Natercia F.; Torres, Lurdes; Brandão, Andreia; Pinheiro, Manuela; Cardoso, Marta; et al. Corresponding author: Paulo, Paula. "Proceedings of the 26th Annual Meeting of the Portuguese Society of Human Genetics (SPGH ¿ Sociedade Portuguesa de Genética Humana) Coimbra, 17¿19 November 2022". 2023.
  6. Silva, Maria P.; Ferreira, Luísa; Brás, Natércia; Torres, Lurdes; Brandão, Andreia; Pinheiro, Manuela; Cardoso, Marta; et al. Corresponding author: Paulo, Paula. "BUB1B monoallelic germline variants contribute to prostate cancer predisposition by triggering chromosomal instability". Paper presented in 26ª Reunião Anual da Sociedade Portuguesa de Genética Humana, 2022.
  7. Canário, Rita; Morgado, Inês; Ribeiro, Ana Sofia; Mendes, Nuno; Teixeira, Manuel R.; BARTOSCH, CARLA; Paredes, Joana. "P-cadherin: a promising prognostic biomarker for homologous repair proficient high grade serous ovarian carcinoma". Paper presented in ESGO 2022 Congress, 2022.
  8. Canário, Rita; Morgado, Inês; Mendes, Nuno; Teixeira, Manuel R.; Ribeiro, Ana Sofia; BARTOSCH, CARLA; Paredes, Joana. Corresponding author: Canário, Rita. "P-cadherin overexpression is associated with shorter overall survival in high grade serous ovarian cancer". Paper presented in ASPIC 5th International Congress, 2022.
  9. Silva, Maria P. ((9618-5B5D-E47A); Ferreira, Luisa; Torres, Lurdes; Brandão, Andreia; Pinheiro, Manuela; Palmeira, Carlos; Maiato, Helder; Paulo, Paula; Teixeira, Manuel R.. Corresponding author: Paulo, Paula. "A recurrent in-frame BUB1B germline variant in prostate cancer predisposition". Paper presented in EMBO Workshop: Systems Approaches in Cancer, 2021.
  10. Pires-Luis, Ana S.; Bartosch, Carla; Meireles, Catarina; Pinto, Carla; Lopes, Jose M.; Shannon, Kristen M.; Teixeira, Manuel R.; Oliva, Esther; José Manuel Lopes. "Hysterectomy Specimens of Patients with Lynch Syndrome: Clinicopathologic Study of 70 Cases". 2016.
  11. Caldas, Margarida; Polónia, António; Vieira, J; Teixeira, Manuel R.; Leal, C. "A case of secretory carcinoma of the breast expressing gross cystic disease fluid protein-15". Paper presented in 25th European Congress of Pathology, 2013.
  12. Jerónimo, Carmen; Monteiro, Paula; Henrique, Rui; Dinis-Ribeiro, Mário; Costa, Vera L.; L. Filipe; Carvalho, André L.; et al. "Marcadores epigenéticos aumentam a acuidade diagnostica em citologia aspirativa de lesões mamárias". Paper presented in 12ªs Jornadas de Oncologia Médica, 2007.
Journal article
  1. Pinto, Emilia M.; Fridman, Cintia; Figueiredo, Bonald C.; Salvador, Hector; Teixeira, Manuel R.; Pinto, Carla; Pinheiro, Manuela; et al. "Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility". Human Genetics and Genomics Advances 5 1 (2024): 100244. http://dx.doi.org/10.1016/j.xhgg.2023.100244.
  2. Wang, Anqi; Shen, Jiayi; Rodriguez, Alex A.; Saunders, Edward J.; Chen, Fei; Janivara, Rohini; Darst, Burcu F.; et al. "Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants". Nature Genetics 55 12 (2023): 2065-2074. http://dx.doi.org/10.1038/s41588-023-01534-4.
    Published • 10.1038/s41588-023-01534-4
  3. Moreira, Inês; Ferreira, Marta; Garcia, Sofia; Novais, Pedro; Gama, João; Ferro, Beatriz; Leite-Silva, Pedro; et al. "Practical lessons learned from real-world implementation of the molecular classification for endometrial carcinoma". Gynecologic Oncology 176 (2023): 53-61. http://dx.doi.org/10.1016/j.ygyno.2023.07.005.
  4. Pinto, Carla; Guerra, Joana; Pinheiro, Manuela; Escudeiro, Carla; Santos, Catarina; Pinto, Pedro; Porto, Miguel; et al. "Combined germline and tumor mutation signature testing identifies new families with NTHL1 tumor syndrome". Frontiers in Genetics 14 (2023): http://dx.doi.org/10.3389/fgene.2023.1254908.
  5. Guerra, Joana; Pinto, Carla; Pinto, Pedro; Pinheiro, Manuela; Santos, Catarina; Peixoto, Ana; Escudeiro, Carla; et al. "Frequency of CDH1, CTNNA1 and CTNND1 Germline Variants in Families with Diffuse and Mixed Gastric Cancer". Cancers 15 17 (2023): 4313. http://dx.doi.org/10.3390/cancers15174313.
  6. Pinheiro, Manuela; Peixoto, Ana; Rocha, Patrícia; Santos, Catarina; Escudeiro, Carla; Veiga, Isabel; Porto, Miguel; et al. "Implementation of upfront DPYD genotyping with a low-cost and high-throughput assay to guide fluoropyrimidine treatment in cancer patients". Pharmacogenetics and Genomics (2023): http://dx.doi.org/10.1097/fpc.0000000000000505.
  7. Paula Paulo; Marta Cardoso; Andreia Brandao; Pinto P; Falconi A; Pinheiro M; Cerveira N; et al. "Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients.". Genes, chromosomes & cancer (2023): https://doi.org/10.1002/gcc.23190.
  8. Burcu Darst; Shen J; Madduri RK; Rodriguez AA; Xiao Y; Sheng X; Saunders EJ; et al. "Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.". American journal of human genetics (2023): https://doi.org/10.1016/j.ajhg.2023.05.010.
  9. Taru Annika Muranen; Morra A; Sofia Khan; Barnes DR; Bolla MK; Joe Dennis; Renske Keeman; et al. "PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants.". NPJ breast cancer (2023): https://europepmc.org/articles/PMC10182045.
  10. Denise G. O'Mahony; Susan Ramus; Southey MC; Nicola S Meagher; Hadjisavvas A; John EM; Hamann U; et al. "Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.". British journal of cancer (2023): https://europepmc.org/articles/PMC10241792.
  11. Marta Cardoso; Sofia Maia; Andreia Brandão; Ruta Sahasrabudhe; Paul Lott; Natalia Belter; Luis G. Carvajal-Carmona; Paula Paulo; Manuel R. Teixeira. "Exome sequencing of affected duos and trios uncovers PRUNE2 as a novel prostate cancer predisposition gene". British Journal of Cancer (2023): https://doi.org/10.1038/s41416-022-02125-6.
  12. Peixoto A; Cirnes L; Carvalho AL; Andrade MJ; Brito MJ; Borralho P; Borralho PM; et al. "Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project.". Frontiers in molecular biosciences (2023): https://europepmc.org/articles/PMC9941536.
  13. Marisa Linhares; Cláudia Marques Pinto; Diogo Libânio; Manuel R. Teixeira; Mário Dinis-Ribeiro; Catarina Brandão. "Gastric Cancer: A Practical Review on Management of Individuals with Hereditary or Familial Risk for Gastric Cancer". GE - Portuguese Journal of Gastroenterology (2023): https://doi.org/10.1159/000527208.
  14. Garcia-Pelaez J; Barbosa-Matos R; Silvana Lobo; Alexandre Dias; Garrido L; Sergio Castedo; Sousa S; et al. "Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.". The Lancet. Oncology (2022): https://europepmc.org/articles/PMC9810541.
  15. Hakkaart C; John F Pearson; Marquart L; Joe Dennis; Wiggins GAR; Daniel Barnes; Robinson BA; et al. "Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.". Communications biology (2022): https://europepmc.org/articles/PMC9537519.
  16. Ana Marote; Santos, Diogo J; Mendes-Pinheiro B; Serre-Miranda C; Anjo SI; Vieira J; Ferreira-Antunes F; et al. "Cellular Aging Secretes: a Comparison of Bone-Marrow-Derived and Induced Mesenchymal Stem Cells and Their Secretome Over Long-Term Culture.". Stem cell reviews and reports (2022): https://doi.org/10.1007/s12015-022-10453-6.
  17. Inês Moreira; Carla Bartosch; Manuel Teixeira; Marta Ferreira. "Molecular Classification of Endometrial Carcinoma: Protocol for a Cohort Study". JMIR Research Protocols (2022): https://doi.org/10.2196/34461.
  18. Teixeira MR; Oliveira J; Borralho P; O Fernandes MG; Almodovar T; Gabriela Fernandes; Macedo D; et al. "Portuguese Consensus Recommendations for Next-Generation Sequencing of Lung Cancer, Rare Tumors, and Cancers of Unknown Primary Origin in Clinical Practice.". Acta medica portuguesa (2022): https://doi.org/10.20344/amp.17680.
  19. Huynh-Le, M.-P.; Karunamuni, R.; Fan, C.C.; Asona, L.; Thompson, W.K.; Martinez, M.E.; Eeles, R.A.; et al. "Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.". Prostate cancer and prostatic diseases (2022): https://doi.org/10.1038/s41391-022-00497-7.
    Published • 10.1038/s41391-022-00497-7
  20. Costa, C.; Souteiro, P.; Paredes, S.; Bettencourt-Silva, R.; Pedro, J.; Ferreira, M.J.; Salazar, D.; et al. "Male gender as a poor prognostic factor in Medullary Thyroid Carcinoma: behaviour or biological difference?". Minerva Endocrinology (2022): http://dx.doi.org/10.23736/s2724-6507.22.03692-2.
  21. Dareng, Eileen O.; Tyrer, Jonathan P.; Barnes, Daniel R.; Jones, Michelle R.; Yang, Xin; Aben, Katja K. H.; Adank, Muriel A.; et al. "Polygenic risk modeling for prediction of epithelial ovarian cancer risk". European Journal of Human Genetics (2022): https://publons.com/publon/50982916/.
  22. Barnes, D.R.; Silvestri, V.; Leslie, G.; McGuffog, L.; Dennis, J.; Yang, X.; Adlard, J.; et al. "Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores". Journal of the National Cancer Institute 114 1 (2022): 109-122. http://www.scopus.com/inward/record.url?eid=2-s2.0-85122613384&partnerID=MN8TOARS.
  23. Custódio, N.; Savisaar, R.; Carvalho, C.; Bak-Gordon, P.; Ribeiro, M.I.; Tavares, J.; Nunes, P.B.; et al. "Expression Profiling in Ovarian Cancer Reveals Coordinated Regulation of BRCA1/2 and Homologous Recombination Genes". Biomedicines 10 2 (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85123732202&partnerID=MN8TOARS.
  24. Pinheiro, Manuela; Peixoto, Ana; Rocha, Patricia; Veiga, Isabel; Pinto, Carla; Santos, Catarina; Pinto, Pedro; et al. "KRAS and NRAS mutational analysis in plasma ctDNA from patients with metastatic colorectal cancer by real-time PCR and digital PCR". International Journal of Colorectal Disease (2022): https://publons.com/wos-op/publon/51838125/.
  25. Lakeman, I.M.M.; van den Broek, A.J.; Vos, J.A.M.; Barnes, D.R.; Adlard, J.; Andrulis, I.L.; Arason, A.; et al. "The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant". Genetics in Medicine 23 9 (2021): 1726-1737. http://www.scopus.com/inward/record.url?eid=2-s2.0-85115935642&partnerID=MN8TOARS.
  26. Escudeiro, C.; Pinto, C.; Vieira, J.; Peixoto, A.; Pinto, P.; Pinheiro, M.; Santos, C.; et al. "The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer". Familial Cancer 20 3 (2021): 173-180. http://www.scopus.com/inward/record.url?eid=2-s2.0-85092355459&partnerID=MN8TOARS.
  27. Marques, I.J.; Gomes, I.; Pojo, M.; Pires, C.; Moura, M.M.; Cabrera, R.; Santos, C.; et al. "Identification of SPRY4 as a novel candidate susceptibility gene for familial nonmedullary thyroid cancer". Thyroid 31 9 (2021): 1366-1375. http://www.scopus.com/inward/record.url?eid=2-s2.0-85115047606&partnerID=MN8TOARS.
  28. Lin, H.-Y.; Huang, P.-Y.; Cheng, C.-H.; Tung, H.-Y.; Fang, Z.; Berglund, A.E.; Chen, A.; et al. "KLK3 SNP–SNP interactions for prediction of prostate cancer aggressiveness". Scientific Reports 11 1 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85105127432&partnerID=MN8TOARS.
  29. Bancroft, E.K.; Page, E.C.; Brook, M.N.; Thomas, S.; Taylor, N.; Pope, J.; McHugh, J.; et al. "A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study". The Lancet. Oncology 22 11 (2021): 1618-1631. http://www.scopus.com/inward/record.url?eid=2-s2.0-85118246064&partnerID=MN8TOARS.
  30. Huynh-Le, M.-P.; Fan, C.C.; Karunamuni, R.; Thompson, W.K.; Martinez, M.E.; Eeles, R.A.; Kote-Jarai, Z.; et al. "Polygenic hazard score is associated with prostate cancer in multi-ethnic populations". Nature Communications 12 1 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85101701053&partnerID=MN8TOARS.
  31. Duarte, D.B.; Ferreira, L.; Santos, A.P.; Costa, C.; Lima, J.; Santos, C.; Afonso, M.; et al. "Case Report: Pheochromocytoma and Synchronous Neuroblastoma in a Family With Hereditary Pheochromocytoma Associated With a MAX Deleterious Variant". Frontiers in Endocrinology 12 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85103508527&partnerID=MN8TOARS.
  32. Petronilho, S.; Sequeira, J.P.; Paulino, S.; Lopes, P.; Lisboa, S.; Chacim, S.; Lobo, J.; et al. "Prognostic value of histone modifying enzyme EZH2 in RCHOP-treated diffuse large B-cell lymphoma and high grade B-cell lymphoma". Journal of Personalized Medicine 11 12 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85121615245&partnerID=MN8TOARS.
  33. Karlsson, Q.; Brook, M.N.; Dadaev, T.; Wakerell, S.; Saunders, E.J.; Muir, K.; Neal, D.E.; et al. "Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study". European urology oncology 4 4 (2021): 570-579. http://www.scopus.com/inward/record.url?eid=2-s2.0-85100645237&partnerID=MN8TOARS.
  34. Karunamuni, R.A.; Huynh-Le, M.-P.; Fan, C.C.; Thompson, W.; Eeles, R.A.; Kote-Jarai, Z.; Muir, K.; et al. "Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer". Prostate Cancer and Prostatic Diseases 24 2 (2021): 532-541. http://www.scopus.com/inward/record.url?eid=2-s2.0-85102762943&partnerID=MN8TOARS.
  35. Pereira, F.; Teixeira, M.R.; Dinis Ribeiro, M.; Brandão, C.. "Multi-Gene Panel Testing in Gastroenterology: Are We Ready for the Results?". GE Portuguese Journal of Gastroenterology 28 6 (2021): 403-409. http://www.scopus.com/inward/record.url?eid=2-s2.0-85100744969&partnerID=MN8TOARS.
  36. Conti, D.V.; Darst, B.F.; Moss, L.C.; Saunders, E.J.; Sheng, X.; Chou, A.; Schumacher, F.R.; et al. "Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction". Nature Genetics 53 1 (2021): 65-75. http://www.scopus.com/inward/record.url?eid=2-s2.0-85098923871&partnerID=MN8TOARS.
  37. Cerveira, N.; Bizarro, S.; Teixeira, M.R.; Mariz, J.M.. "When to Stop TKIs in Patients with Chronic Myeloid Leukemia and How to Follow Them Subsequently". Current Treatment Options in Oncology 22 6 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85104519120&partnerID=MN8TOARS.
  38. Barbosa, A.; Pinto, P.; Peixoto, A.; Guerra, J.; Pinheiro, M.; Santos, C.; Pinto, C.; et al. "Next Generation Sequencing of Tumor and Matched Plasma Samples: Identification of Somatic Variants in ctDNA From Ovarian Cancer Patients". Frontiers in Oncology 11 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85117094719&partnerID=MN8TOARS.
  39. Couto, M.E.; Bizarro, S.; Sousa, D.; Domingues, N.; Oliveira, I.; Martins, G.; Teixeira, M.R.; Mariz, M.. "Myeloid Disease with the CSF3R T618I Mutation after CLL". Case Reports in Hematology 2020 (2020): 1-4. http://dx.doi.org/10.1155/2020/6670965.
  40. Fachal, L.; Aschard, H.; Beesley, J.; Barnes, D.R.; Allen, J.; Kar, S.; Pooley, K.A.; et al. "Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes". Nature Genetics 52 1 (2020): 56-73. http://www.scopus.com/inward/record.url?eid=2-s2.0-85077675544&partnerID=MN8TOARS.
  41. Escala-Garcia, M.; Abraham, J.; Andrulis, I.L.; Anton-Culver, H.; Arndt, V.; Ashworth, A.; Auer, P.L.; et al. "A network analysis to identify mediators of germline-driven differences in breast cancer prognosis". Nature Communications 11 1 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85077940819&partnerID=MN8TOARS.
  42. Figlioli, G.; Kvist, A.; Tham, E.; Soukupova, J.; Kleiblova, P.; Muranen, T.A.; Andrieu, N.; et al. "The spectrum of fancm protein truncating variants in European breast cancer cases". Cancers 12 2 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85078848552&partnerID=MN8TOARS.
  43. Feng, H.; Gusev, A.; Pasaniuc, B.; Wu, L.; Long, J.; Abu-full, Z.; Aittomäki, K.; et al. "Transcriptome-wide association study of breast cancer risk by estrogen-receptor status". Genetic Epidemiology (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85081379482&partnerID=MN8TOARS.
  44. Patel, V.L.; Busch, E.L.; Friebel, T.M.; Cronin, A.; Leslie, G.; McGuffog, L.; Adlard, J.; et al. "Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness". Cancer Research 80 3 (2020): 624-638. http://www.scopus.com/inward/record.url?eid=2-s2.0-85079022145&partnerID=MN8TOARS.
  45. Barnes, D.R.; Rookus, M.A.; McGuffog, L.; Leslie, G.; Mooij, T.M.; Dennis, J.; Mavaddat, N.; et al. "Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants". Genetics in Medicine 22 10 (2020): 1653-1666. http://www.scopus.com/inward/record.url?eid=2-s2.0-85091841899&partnerID=MN8TOARS.
  46. Karunamuni, R.A.; Huynh-Le, M.-P.; Fan, C.C.; Eeles, R.A.; Easton, D.F.; Kote-Jarai, Z.S.; Amin Al Olama, A.; et al. "The effect of sample size on polygenic hazard models for prostate cancer". European Journal of Human Genetics 28 10 (2020): 1467-1475. http://www.scopus.com/inward/record.url?eid=2-s2.0-85086170171&partnerID=MN8TOARS.
  47. Brandão, A.; Paulo, P.; Teixeira, M.R.. "Hereditary predisposition to prostate cancer: From genetics to clinical implications". International Journal of Molecular Sciences 21 14 (2020): 1-23. http://www.scopus.com/inward/record.url?eid=2-s2.0-85088485750&partnerID=MN8TOARS.
  48. Pinheiro, M.; Peixoto, A.; Santos, C.; Escudeiro, C.; Bizarro, S.; Pinto, P.; Santos, R.; et al. "Pathogenicity reclassification of two BRCA1/BRCA2 exonic duplications after identification of genomic breakpoints and tandem orientation". Cancer Genetics 248-249 (2020): 18-24. http://www.scopus.com/inward/record.url?eid=2-s2.0-85091235182&partnerID=MN8TOARS.
  49. Huynh-Le, M.-P.; Fan, C.C.; Karunamuni, R.; Walsh, E.I.; Turner, E.L.; Athene Lane, J.; Martin, R.M.; et al. "A genetic risk score to personalize prostate cancer screening, applied to population data". Cancer Epidemiology Biomarkers and Prevention 29 9 (2020): 1731-1738. http://www.scopus.com/inward/record.url?eid=2-s2.0-85096010016&partnerID=MN8TOARS.
  50. Lobo, J.; Pinto, C.; Pinheiro, M.; Lobo, F.; Sousa, N.; Lopes, P.; Looijenga, L.H.J.; et al. "Widening the spectrum of Lynch syndrome: first report of testicular seminoma attributable to MSH2 loss". Histopathology 76 3 (2020): 486-489. http://www.scopus.com/inward/record.url?eid=2-s2.0-85073749849&partnerID=MN8TOARS.
  51. Muranen, T.A.; Khan, S.; Fagerholm, R.; Aittomäki, K.; Cunningham, J.M.; Dennis, J.; Leslie, G.; et al. "Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer". npj Breast Cancer 6 1 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85090501112&partnerID=MN8TOARS.
  52. Barbosa, A.; Pinto, P.; Peixoto, A.; Guerra, J.; Pinto, C.; Santos, C.; Pinheiro, M.; et al. "Gene panel tumor testing in ovarian cancer patients significantly increases the yield of clinically actionable germline variants beyond BRCA1/BRCA2". Cancers 12 10 (2020): 1-16. http://www.scopus.com/inward/record.url?eid=2-s2.0-85091853327&partnerID=MN8TOARS.
  53. Martins, R.G.; Cunha, N.; Simões, H.; Matos, M.J.; Silva, J.; Torres, I.; Rodrigues, F.; et al. "Surveillance of succinate dehydrogenase gene mutation carriers: Insights from a nationwide cohort". Clinical Endocrinology 92 6 (2020): 545-553. http://www.scopus.com/inward/record.url?eid=2-s2.0-85083494328&partnerID=MN8TOARS.
  54. Peixoto, A.; Pinto, P.; Guerra, J.; Pinheiro, M.; Santos, C.; Pinto, C.; Santos, R.; et al. "Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects". Frontiers in Oncology 10 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85089524652&partnerID=MN8TOARS.
  55. Tuazon, A.M.A.; Lott, P.; Bohórquez, M.; Benavides, J.; Ramirez, C.; Criollo, A.; Estrada-Florez, A.; et al. "Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia". Breast cancer research : BCR 22 1 (2020): 108-108. http://www.scopus.com/inward/record.url?eid=2-s2.0-85094153616&partnerID=MN8TOARS.
  56. Brandão, A.; Paulo, P.; Maia, S.; Pinheiro, M.; Peixoto, A.; Cardoso, M.; Silva, M.P.; et al. "The CHEK2 variant C.349A>G is associated with prostate cancer risk and carriers share a common ancestor". Cancers 12 11 (2020): 1-17. http://www.scopus.com/inward/record.url?eid=2-s2.0-85096384312&partnerID=MN8TOARS.
  57. Silvestri, V.; Leslie, G.; Barnes, D.R.; Agnarsson, B.A.; Aittomäki, K.; Alducci, E.; Andrulis, I.L.; et al. "Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)". JAMA Oncology 6 8 (2020): 1218-1230. http://www.scopus.com/inward/record.url?eid=2-s2.0-85088708548&partnerID=MN8TOARS.
  58. Zhang, H.; Ahearn, T.U.; Lecarpentier, J.; Barnes, D.; Beesley, J.; Qi, G.; Jiang, X.; et al. "Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses". Nature Genetics 52 6 (2020): 572-581. http://www.scopus.com/inward/record.url?eid=2-s2.0-85085167024&partnerID=MN8TOARS.
  59. Adams, C.D.; Richmond, R.; Santos Ferreira, D.L.; Spiller, W.; Tan, V.; Zheng, J.; Würtz, P.; et al. "Circulating metabolic biomarkers of screen-detected prostate cancer in the ProtecT study". Cancer Epidemiology Biomarkers and Prevention 28 1 (2019): 208-216. http://www.scopus.com/inward/record.url?eid=2-s2.0-85059928972&partnerID=MN8TOARS.
  60. Jiang, X.; Finucane, H.K.; Schumacher, F.R.; Schmit, S.L.; Tyrer, J.P.; Han, Y.; Michailidou, K.; et al. "Shared heritability and functional enrichment across six solid cancers". Nature Communications 10 1 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85060528251&partnerID=MN8TOARS.
  61. Singer, C.F.; Balmaña, J.; Bürki, N.; Delaloge, S.; Filieri, M.E.; Gerdes, A.-M.; Grindedal, E.M.; et al. "Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations". European Journal of Cancer 106 (2019): 54-60. http://www.scopus.com/inward/record.url?eid=2-s2.0-85056856124&partnerID=MN8TOARS.
  62. Escala-Garcia, M.; Guo, Q.; Dörk, T.; Canisius, S.; Keeman, R.; Dennis, J.; Beesley, J.; et al. "Genome-wide association study of germline variants and breast cancer-specific mortality". British Journal of Cancer 120 6 (2019): 647-657. http://www.scopus.com/inward/record.url?eid=2-s2.0-85061925826&partnerID=MN8TOARS.
  63. Page, E.C.; Bancroft, E.K.; Brook, M.N.; Assel, M.; Hassan Al Battat, M.; Thomas, S.; Taylor, N.; et al. "Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers". European Urology 76 6 (2019): 831-842. http://www.scopus.com/inward/record.url?eid=2-s2.0-85074388214&partnerID=MN8TOARS.
  64. Cerveira, N.; Diamond, J.; Matos, S.; Amorim, M.L.; Coucelo, M.; Bizarro, S.; Simões, A.T.; et al. "Negative MR4·0 chronic myeloid leukaemia and its possible implications for treatment-free remission". British Journal of Haematology 186 6 (2019): e181-e184. http://www.scopus.com/inward/record.url?eid=2-s2.0-85067473220&partnerID=MN8TOARS.
  65. Figlioli, G.; Bogliolo, M.; Catucci, I.; Caleca, L.; Lasheras, S.V.; Pujol, R.; Kiiski, J.I.; et al. "The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer". npj Breast Cancer 5 1 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85074364016&partnerID=MN8TOARS.
  66. Qian, F.; Wang, S.; Mitchell, J.; McGuffog, L.; Barrowdale, D.; Leslie, G.; Oosterwijk, J.C.; et al. "Height and body mass index as Modifiers of breast cancer risk in BRCA1/2 mutation carriers: A Mendelian randomization study". Journal of the National Cancer Institute 111 4 (2019): 350-364. http://www.scopus.com/inward/record.url?eid=2-s2.0-85064286333&partnerID=MN8TOARS.
  67. Pinheiro, M.; Francisco, I.; Pinto, C.; Peixoto, A.; Veiga, I.; Filipe, B.; Santos, C.; et al. "The nonsense mutation MSH2 c.2152C>T shows a founder effect in Portuguese Lynch syndrome families". Genes Chromosomes and Cancer 58 9 (2019): 657-664. http://www.scopus.com/inward/record.url?eid=2-s2.0-85065014893&partnerID=MN8TOARS.
  68. Qian, F.; Rookus, M.A.; Leslie, G.; Risch, H.A.; Greene, M.H.; Aalfs, C.M.; Adank, M.A.; et al. "Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers". British Journal of Cancer 121 2 (2019): 180-192. http://www.scopus.com/inward/record.url?eid=2-s2.0-85067846442&partnerID=MN8TOARS.
  69. Ferreira, M.A.; Gamazon, E.R.; Al-Ejeh, F.; Aittomäki, K.; Andrulis, I.L.; Anton-Culver, H.; Arason, A.; et al. "Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer". Nature Communications 10 1 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85064432929&partnerID=MN8TOARS.
  70. Cerveira, N.; Loureiro, B.; Bizarro, S.; Correia, C.; Torres, L.; Lisboa, S.; Vieira, J.; et al. "Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution". BMC Cancer 18 1 (2018): 1245. http://dx.doi.org/10.1186/s12885-018-5167-y.
  71. Pinto, D.; Pinto, C.; Guerra, J.; Pinheiro, M.; Santos, R.; Vedeld, H.M.; Yohannes, Z.; et al. "Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation". Cancer Medicine 7 2 (2018): 433-444. http://www.scopus.com/inward/record.url?eid=2-s2.0-85040657087&partnerID=MN8TOARS.
  72. Fewings, E.; Larionov, A.; Redman, J.; Goldgraben, M.A.; Scarth, J.; Richardson, S.; Brewer, C.; et al. "Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study". The Lancet Gastroenterology and Hepatology (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85046162774&partnerID=MN8TOARS.
  73. Mikropoulos, C.; Selkirk, C.G.H.; Saya, S.; Bancroft, E.; Vertosick, E.; Dadaev, T.; Brendler, C.; et al. "Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition". British Journal of Cancer 118 2 (2018): 266-276. http://www.scopus.com/inward/record.url?eid=2-s2.0-85041064923&partnerID=MN8TOARS.
  74. Caputo, S.M.; Léone, M.; Damiola, F.; Ehlen, A.; Carreira, A.; Gaidrat, P.; Martins, A.; et al. "Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer". Oncotarget 9 25 (2018): 17334-17348. http://www.scopus.com/inward/record.url?eid=2-s2.0-85044827158&partnerID=MN8TOARS.
  75. Rebbeck, T.R.; Friebel, T.M.; Friedman, E.; Hamann, U.; Huo, D.; Kwong, A.; Olah, E.; et al. "Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations". Human Mutation 39 5 (2018): 593-620. http://www.scopus.com/inward/record.url?eid=2-s2.0-85043494756&partnerID=MN8TOARS.
  76. Seibert, T.M.; Fan, C.C.; Wang, Y.; Zuber, V.; Karunamuni, R.; Parsons, J.K.; Eeles, R.A.; et al. "Polygenic hazard score to guide screening for aggressive prostate cancer: Development and validation in large scale cohorts". BMJ (Online) 360 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85040518909&partnerID=MN8TOARS.
  77. Barbosa, A.; Peixoto, A.; Pinto, P.; Pinheiro, M.; Teixeira, M.R.. Corresponding author: Teixeira, M.R.. "Potential clinical applications of circulating cell-free DNA in ovarian cancer patients". Expert Reviews in Molecular Medicine 20 (2018): E6. http://dx.doi.org/10.1017/erm.2018.5.
  78. Paulo, P.; Maia, S.; Pinto, C.; Pinto, P.; Monteiro, A.; Peixoto, A.; Teixeira, M.R.. Corresponding author: Teixeira, M.R.. "Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer". PLoS Genetics 14 4 (2018): e1007355. http://www.scopus.com/inward/record.url?eid=2-s2.0-85046415026&partnerID=MN8TOARS.
    Published • 10.1371/journal.pgen.1007355
  79. Matejcic, M.; Saunders, E.J.; Dadaev, T.; Brook, M.N.; Wang, K.; Sheng, X.; Olama, A.A.A.; et al. "Germline variation at 8q24 and prostate cancer risk in men of European ancestry". Nature Communications 9 1 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85056250910&partnerID=MN8TOARS.
  80. Lu, Y.; Beeghly-Fadiel, A.; Wu, L.; Guo, X.; Li, B.; Schildkraut, J.M.; Im, H.K.; et al. "A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk". Cancer Research 78 18 (2018): 5419-5430. http://www.scopus.com/inward/record.url?eid=2-s2.0-85053297183&partnerID=MN8TOARS.
  81. Felicio, P.S.; Alemar, B.; Coelho, A.S.; Berardinelli, G.N.; Melendez, M.E.; Lengert, A.V.H.; Miche lli, R.D.; et al. "Screening and characterization of BRCA2 c.156_157insAlu in Brazil: Results from 1380 individuals from the South and Southeast". Cancer Genetics 228-229 (2018): 93-97. http://www.scopus.com/inward/record.url?eid=2-s2.0-85056169948&partnerID=MN8TOARS.
  82. Nielsen, S.M.; Eccles, D.M.; Romero, I.L.; Al-Mulla, F.; Balmaña, J.; Biancolella, M.; Blok, R.; et al. "Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and breast/ovarian) cancer susceptibility genes: An international survey by the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) clinical working group". JCO Precision Oncology 2 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85073273493&partnerID=MN8TOARS.
  83. Cerveira, N.; Ferreira, R.B.; Bizarro, S.; Correia, C.; Torres, L.; Lisboa, S.; Vieira, J.; et al. "Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: A case report". BMC Cancer 18 1 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85058034598&partnerID=MN8TOARS.
  84. Pires-Luis, A.; Montezuma, D.; Vieira, J.; Ramalho-Carvalho, J.; Santos, C.; Teixeira, M.; Jerónimo, C.; Henrique, R.. "Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case". Experimental and Molecular Pathology 105 3 (2018): 352-356. http://www.scopus.com/inward/record.url?eid=2-s2.0-85055521380&partnerID=MN8TOARS.
  85. Lin, H.-Y.; Huang, P.-Y.; Chen, D.-T.; Tung, H.-Y.; Sellers, T.A.; Pow-Sang, J.M.; Eeles, R.; et al. "AA9int: SNP interaction pattern search using non-hierarchical additive model set". Bioinformatics (Oxford, England) 34 24 (2018): 4141-4150. http://www.scopus.com/inward/record.url?eid=2-s2.0-85058913751&partnerID=MN8TOARS.
  86. Schumacher, F.R.; Al Olama, A.A.; Berndt, S.I.; Benlloch, S.; Ahmed, M.; Saunders, E.J.; Dadaev, T.; et al. "Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci". Nature Genetics 50 7 (2018): 928-936. http://www.scopus.com/inward/record.url?eid=2-s2.0-85048333838&partnerID=MN8TOARS.
  87. Dadaev, T.; Saunders, E.J.; Newcombe, P.J.; Anokian, E.; Leongamornlert, D.A.; Brook, M.N.; Cieza-Borrella, C.; et al. "Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants". Nature Communications 9 1 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85048420948&partnerID=MN8TOARS.
  88. Guerra, J.; Pinto, C.; Pinto, D.; Pinheiro, M.; Silva, R.; Peixoto, A.; Rocha, P.; et al. Corresponding author: Teixeira, M.R.. "POLE somatic mutations in advanced colorectal cancer". Cancer Medicine 6 12 (2017): 2966-2971. https://doi.org/10.1002/cam4.1245.
  89. Taylor, A.E.; Martin, R.M.; Geybels, M.S.; Stanford, J.L.; Shui, I.; Eeles, R.; Easton, D.; et al. "Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis". International Journal of Cancer 140 2 (2017): 322-328. http://www.scopus.com/inward/record.url?eid=2-s2.0-84995982193&partnerID=MN8TOARS.
  90. Hamdi, Y.; Soucy, P.; Kuchenbaeker, K.B.; Pastinen, T.; Droit, A.; Lema�on, A.; Adlard, J.; et al. "Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3". Breast Cancer Research and Treatment 161 1 (2017): 117-134. http://www.scopus.com/inward/record.url?eid=2-s2.0-84992735226&partnerID=MN8TOARS.
  91. Marques, I.J.; Moura, M.M.; Cabrera, R.; Pinto, A.E.; Simões-Pereira, J.; Santos, C.; Menezes, F.D.; et al. "Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas". Clinical Endocrinology 87 4 (2017): 394-399. http://www.scopus.com/inward/record.url?eid=2-s2.0-85020539300&partnerID=MN8TOARS.
  92. Lobo, J.; Pinto, C.; Freitas, M.; Pinheiro, M.; Vizcaino, R.; Oliva, E.; Teixeira, M.R.; Jerónimo, C.; Bartosch, C.. "Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?". Virchows Archiv 470 3 (2017): 347-352. http://www.scopus.com/inward/record.url?eid=2-s2.0-85000893294&partnerID=MN8TOARS.
  93. Cabreira, V.; Pinto, C.; Pinheiro, M.; Lopes, P.; Peixoto, A.; Santos, C.; Veiga, I.; et al. "Performance of Lynch syndrome predictive models in quantifying the likelihood of germline mutations in patients with abnormal MLH1 immunoexpression". Familial Cancer 16 1 (2017): 73-81. http://www.scopus.com/inward/record.url?eid=2-s2.0-84984791464&partnerID=MN8TOARS.
  94. Kuchenbaecker, K.B.; McGuffog, L.; Barrowdale, D.; Lee, A.; Soucy, P.; Dennis, J.; Domchek, S.M.; et al. "Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers". Journal of the National Cancer Institute 109 7 (2017): djw302. http://www.scopus.com/inward/record.url?eid=2-s2.0-85016213460&partnerID=MN8TOARS.
    Published • 10.1093/jnci/djw302
  95. Sahasrabudhe, R.; Lott, P.; Bohorquez, M.; Toal, T.; Estrada, A.P.; Suarez, J.J.; Brea-Fernández, A.; et al. "Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer". Gastroenterology 152 5 (2017): 983-986.e6. http://www.scopus.com/inward/record.url?eid=2-s2.0-85016201532&partnerID=MN8TOARS.
  96. Milne, R.L.; Kuchenbaecker, K.B.; Michailidou, K.; Beesley, J.; Kar, S.; Lindström, S.; Hui, S.; et al. "Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer". Nature Genetics 49 12 (2017): 1767-1778. http://www.scopus.com/inward/record.url?eid=2-s2.0-85035773185&partnerID=MN8TOARS.
  97. Lin, H.-Y.; Chen, D.-T.; Huang, P.-Y.; Liu, Y.-H.; Ochoa, A.; Zabaleta, J.; Mercante, D.E.; et al. "SNP interaction pattern identifier (SIPI): An intensive search for SNP-SNP interaction patterns". Bioinformatics 33 6 (2017): 822-833. http://www.scopus.com/inward/record.url?eid=2-s2.0-85018245832&partnerID=MN8TOARS.
  98. Paulo, P.; Pinto, P.; Peixoto, A.; Santos, C.; Pinto, C.; Rocha, P.; Veiga, I.; et al. Corresponding author: Teixeira, M.R.. "Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes". Journal of Molecular Diagnostics 19 4 (2017): 502-513. http://www.scopus.com/inward/record.url?eid=2-s2.0-85021295082&partnerID=MN8TOARS.
  99. Brunner, C.; Davies, N.M.; Martin, R.M.; Eeles, R.; Easton, D.; Kote-Jarai, Z.; Al Olama, A.A.; et al. "Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study". International Journal of Cancer 140 1 (2017): 75-85. http://www.scopus.com/inward/record.url?eid=2-s2.0-84991075562&partnerID=MN8TOARS.
  100. Lecarpentier, J.; Kuchenbaecker, K.B.; Barrowdale, D.; Dennis, J.; McGuffog, L.; Leslie, G.; Lee, A.; et al. "Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores". Journal of Clinical Oncology 35 20 (2017): 2240-2250. http://www.scopus.com/inward/record.url?eid=2-s2.0-85024491245&partnerID=MN8TOARS.
  101. Phelan, C.M.; Kuchenbaecker, K.B.; Tyrer, J.P.; Kar, S.P.; Lawrenson, K.; Winham, S.J.; Dennis, J.; et al. "Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer". Nature Genetics 49 5 (2017): 680-691. http://www.scopus.com/inward/record.url?eid=2-s2.0-85016117389&partnerID=MN8TOARS.
  102. Cardoso, M.; Paulo, P.; Maia, S.; Teixeira, M.R.. Corresponding author: Teixeira, M.R.. "Truncating and missensePPM1Dmutations in early-onset and/or familial/hereditary prostate cancer patients". Genes, Chromosomes and Cancer 55 12 (2016): 954-961. http://dx.doi.org/10.1002/gcc.22393.
  103. Maia, S.; Cardoso, M.; Paulo, P.; Pinheiro, M.; Pinto, P.; Santos, C.; Pinto, C.; et al. "The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer". Familial Cancer 15 1 (2016): 111-121. http://www.scopus.com/inward/record.url?eid=2-s2.0-84952865189&partnerID=MN8TOARS.
  104. Ewald, I.P.; Cossio, S.L.; Palmero, E.I.; Pinheiro, M.; Nascimento, I.L.O.; Machado, T.M.B.; Sandes, K.A.; et al. "BRCA1 and BRCA2 rearrangements in Brazilian individuals with hereditary breast and ovarian cancer syndrome". Genetics and Molecular Biology 39 2 (2016): 223-231. http://www.scopus.com/inward/record.url?eid=2-s2.0-84974792733&partnerID=MN8TOARS.
  105. Lawrenson, K.; Kar, S.; McCue, K.; Kuchenbaeker, K.; Michailidou, K.; Tyrer, J.; Beesley, J.; et al. "Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus". Nature Communications 7 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84987880304&partnerID=MN8TOARS.
  106. Southey, M.C.; Goldgar, D.E.; Winqvist, R.; Pylkäs, K.; Couch, F.; Tischkowitz, M.; Foulkes, W.D.; et al. "PALB2, CHEK2 and ATM rare variants and cancer risk: Data from COGS". Journal of Medical Genetics 53 12 (2016): 800-811. http://www.scopus.com/inward/record.url?eid=2-s2.0-84986246968&partnerID=MN8TOARS.
  107. Luedeke, M.; Rinckleb, A.E.; FitzGerald, L.M.; Geybels, M.S.; Schleutker, J.; Eeles, R.A.; Teixeira, M.R.; et al. "Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2: ERG fusion status". Human Molecular Genetics 25 24 (2016): 5490-5499. http://www.scopus.com/inward/record.url?eid=2-s2.0-85016002209&partnerID=MN8TOARS.
  108. Kinnersley, B.; Chubb, D.; Dobbins, S.E.; Frampton, M.; Buch, S.; Timofeeva, M.N.; Castellvi-Bel, S.; et al. "Correspondence: SEMA4A variation and risk of colorectal cancer". Nature Communications 7 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84960510389&partnerID=MN8TOARS.
  109. Vigorito, E.; Kuchenbaecker, K.B.; Beesley, J.; Adlard, J.; Agnarsson, B.A.; Andrulis, I.L.; Arun, B.K.; et al. "Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers". PloS one 11 7 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-85016937957&partnerID=MN8TOARS.
  110. Gusev, A.; Shi, H.; Kichaev, G.; Pomerantz, M.; Li, F.; Long, H.W.; Ingles, S.A.; et al. "Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation". Nature Communications 7 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84963635486&partnerID=MN8TOARS.
  111. Dunning, A.M.; Michailidou, K.; Kuchenbaecker, K.B.; Thompson, D.; French, J.D.; Beesley, J.; Healey, C.S.; et al. "Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170". Nature Genetics 48 4 (2016): 374-386. http://www.scopus.com/inward/record.url?eid=2-s2.0-84962106221&partnerID=MN8TOARS.
  112. Sousa, N.; Sousa, O.; Santos, L.L.; Henrique, R.; Teixeira, M.R.; Dinis-Ribeiro, M.; Teixeira-Pinto, A.. "Lapatinib-capecitabine versus capecitabine alone as radiosensitizers in RAS wild-type resectable rectal cancer, an adaptive randomized phase II trial (LaRRC trial): Study protocol for a randomized controlled trial". Trials 17 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84988535628&partnerID=MN8TOARS.
  113. Georgiou, K.; Chen, L.; Berglund, M.; Ren, W.; De Miranda, N.F.C.C.; Lisboa, S.; Fangazio, M.; et al. "Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas". Blood 127 24 (2016): 3026-3034. http://www.scopus.com/inward/record.url?eid=2-s2.0-84995673546&partnerID=MN8TOARS.
  114. Bartosch, C.; Pires-Luís, A.S.; Meireles, C.; Baptista, M.; Gouveia, A.; Pinto, C.; Shannon, K.M.; et al. "Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients with Lynch Syndrome". American Journal of Surgical Pathology 40 9 (2016): 1177-1191. http://www.scopus.com/inward/record.url?eid=2-s2.0-84976330403&partnerID=MN8TOARS.
  115. Couch, F.J.; Kuchenbaecker, K.B.; Michailidou, K.; Mendoza-Fandino, G.A.; Nord, S.; Lilyquist, J.; Olswold, C.; et al. "Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer". Nature Communications 7 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84968760294&partnerID=MN8TOARS.
  116. Bonilla, C.; Lewis, S.J.; Martin, R.M.; Donovan, J.L.; Hamdy, F.C.; Neal, D.E.; Eeles, R.; et al. "Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort". BMC Medicine 14 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-85007425384&partnerID=MN8TOARS.
  117. Pinto, C.; Pinheiro, M.; Peixoto, A.; Santos, C.; Veiga, I.; Rocha, P.; Pinto, P.; et al. "Co-occurrence of nonsense mutations in MSH6 and MSH2 in Lynch syndrome families evidencing that not all truncating mutations are equal". Journal of Human Genetics 61 2 (2016): 151-156. http://www.scopus.com/inward/record.url?eid=2-s2.0-84959281354&partnerID=MN8TOARS.
    Published • 10.1038/jhg.2015.124
  118. Pinto, P.; Paulo, P.; Santos, C.; Rocha, P.; Pinto, C.; Veiga, I.; Pinheiro, M.; Peixoto, A.; Teixeira, M.R.. "Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity". Breast Cancer Research and Treatment 159 2 (2016): 245-256. http://www.scopus.com/inward/record.url?eid=2-s2.0-84983380158&partnerID=MN8TOARS.
  119. Pinto, P.; Peixoto, A.; Santos, C.; Rocha, P.; Pinto, C.; Pinheiro, M.; Leça, L.; et al. "Analysis of founder mutations in rare tumors associated with hereditary breast/ovarian cancer reveals a novel association of BRCA2 mutations with ampulla of vater carcinomas". PLoS ONE 11 8 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84984839635&partnerID=MN8TOARS.
  120. Bonilla, C.; Lewis, S.J.; Rowlands, M.-A.; Gaunt, T.R.; Davey Smith, G.; Gunnell, D.; Palmer, T.; et al. "Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels". International Journal of Cancer 139 7 (2016): 1520-1533. http://www.scopus.com/inward/record.url?eid=2-s2.0-84978264652&partnerID=MN8TOARS.
  121. Silva, M.P.; Barros-Silva, J.D.; Vieira, J.; Lisboa, S.; Torres, L.; Correia, C.; Vieira-Coimbra, M.; et al. "NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer". Genes Chromosomes and Cancer 55 4 (2016): 365-374. http://www.scopus.com/inward/record.url?eid=2-s2.0-84958748922&partnerID=MN8TOARS.
  122. Saunders, E.J.; Dadaev, T.; Leongamornlert, D.A.; Al Olama, A.A.; Benlloch, S.; Giles, G.G.; Wiklund, F.; et al. "Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array". British Journal of Cancer 114 8 (2016): 945-952. http://www.scopus.com/inward/record.url?eid=2-s2.0-84963650435&partnerID=MN8TOARS.
  123. Khankari, N.K.; Murff, H.J.; Zeng, C.; Wen, W.; Eeles, R.A.; Easton, D.F.; Kote-Jarai, Z.; et al. "Polyunsaturated fatty acids and prostate cancer risk: A Mendelian randomisation analysis from the PRACTICAL consortium". British Journal of Cancer 115 5 (2016): 624-631. http://www.scopus.com/inward/record.url?eid=2-s2.0-84982918768&partnerID=MN8TOARS.
  124. Rebbeck, T.R.; Friebel, T.M.; Mitra, N.; Wan, F.; Chen, S.; Andrulis, I.L.; Apostolou, P.; et al. "Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women". Breast Cancer Research 18 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-85000995840&partnerID=MN8TOARS.
  125. Cardoso, M.; Maia, S.; Paulo, P.; Teixeira, M.R.. "Oncogenic mechanisms of HOXB13 missense mutations in prostate carcinogenesis". Oncoscience 3 9-10 (2016): 288-296. http://www.scopus.com/inward/record.url?eid=2-s2.0-84995388277&partnerID=MN8TOARS.
  126. Bull, C.J.; Bonilla, C.; Holly, J.M.P.; Perks, C.M.; Davies, N.; Haycock, P.; Yu, O.H.Y.; et al. "Blood lipids and prostate cancer: a Mendelian randomization analysis". Cancer Medicine 5 6 (2016): 1125-1136. http://www.scopus.com/inward/record.url?eid=2-s2.0-85006190464&partnerID=MN8TOARS.
  127. Zeng, C.; Guo, X.; Long, J.; Kuchenbaecker, K.B.; Droit, A.; Michailidou, K.; Ghoussaini, M.; et al. "Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus". Breast Cancer Research 18 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84979647977&partnerID=MN8TOARS.
  128. Kar, S.P.; Beesley, J.; Al Olama, A.A.; Michailidou, K.; Tyrer, J.; Kote-Jarai, Z.A.; Lawrenson, K.; et al. "Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types". Cancer Discovery 6 9 (2016): 1052-1067. http://www.scopus.com/inward/record.url?eid=2-s2.0-85012028638&partnerID=MN8TOARS.
  129. Silvestri, V.; Barrowdale, D.; Mulligan, A.M.; Neuhausen, S.L.; Fox, S.; Karlan, B.Y.; Mitchell, G.; et al. "Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2". Breast Cancer Research 18 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84958120242&partnerID=MN8TOARS.
  130. Meeks, H.D.; Song, H.; Michailidou, K.; Bolla, M.K.; Dennis, J.; Wang, Q.; Barrowdale, D.; et al. "BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers". Journal of the National Cancer Institute 108 2 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84962488384&partnerID=MN8TOARS.
  131. Silva, M.P.; Barros-Silva, J.D.; Ersvær, E.; Kildal, W.; Hveem, T.S.; Pradhan, M.; Vieira, J.; Teixeira, M.R.; Danielsen, H.E.. "Cancer prognosis defined by the combined analysis of 8q, PTEN and ERG". Translational Oncology 9 6 (2016): 575-582. http://www.scopus.com/inward/record.url?eid=2-s2.0-85000962971&partnerID=MN8TOARS.
  132. Hollestelle, A.; van der Baan, F. H.; Berchuck, A.; Johnatty, S. E.; Aben, K. K.; Agnarsson, B. A.; Aittomäki, K.; et al. "No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer". Gynecol Oncol 141 2 (2016): 386-401.
  133. Stegeman, S.; Amankwah, E.; Klein, K.; O'Mara, T.A.; Kim, D.; Lin, H.Y.; Permuth-Wey, J.; et al. "A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer". Cancer Discovery 5 4 (2015): 368-379. http://dx.doi.org/10.1158/2159-8290.cd-14-1057.
  134. Rebbeck, T.R.; Mitra, N.; Wan, F.; Sinilnikova, O.M.; Healey, S.; McGuffog, L.; Chenevix-Trench, G.; et al. "Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer". JAMA - Journal of the American Medical Association 313 13 (2015): 1347-1361. http://www.scopus.com/inward/record.url?eid=2-s2.0-84927556016&partnerID=MN8TOARS.
  135. Peterlongo, P.; Chang-Claude, J.; Moysich, K.B.; Rudolph, A.; Schmutzler, R.K.; Simard, J.; Soucy, P.; et al. "Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers". Cancer Epidemiology Biomarkers and Prevention 24 1 (2015): 308-316. http://www.scopus.com/inward/record.url?eid=2-s2.0-84921028142&partnerID=MN8TOARS.
  136. Painter, J.N.; O'Mara, T.A.; Batra, J.; Cheng, T.; Lose, F.A.; Dennis, J.; Michailidou, K.; et al. "Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk". Human Molecular Genetics 24 5 (2015): 1478-1492. http://www.scopus.com/inward/record.url?eid=2-s2.0-84924440664&partnerID=MN8TOARS.
  137. Vieira, J.; Pinto, C.; Afonso, M.; Do Bom Sucesso, M.; Lopes, P.; Pinheiro, M.; Veiga, I.; Henrique, R.; Teixeira, M.R.. "Identification of previously unrecognized FAP in children with Gardner fibroma". European Journal of Human Genetics 23 5 (2015): 715-718. http://www.scopus.com/inward/record.url?eid=2-s2.0-84928073639&partnerID=MN8TOARS.
  138. Maia, S.; Cardoso, M.; Pinto, P.; Pinheiro, M.; Santos, C.; Peixoto, A.; Bento, M.J.; et al. "Identification of two novel HOXB13 germline mutations in Portuguese prostate cancer patients". PLoS ONE 10 7 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84941354860&partnerID=MN8TOARS.
  139. Al Olama, A.A.; Dadaev, T.; Hazelett, D.J.; Li, Q.; Leongamornlert, D.; Saunders, E.J.; Stephens, S.; et al. "Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans". Human Molecular Genetics 24 19 (2015): 5589-5602. http://www.scopus.com/inward/record.url?eid=2-s2.0-84943753608&partnerID=MN8TOARS.
  140. Szulkin, R.; Whitington, T.; Eklund, M.; Aly, M.; Eeles, R.A.; Easton, D.; Kote-Jarai, Z.; et al. "Prediction of individual genetic risk to prostate cancer using a polygenic score". Prostate 75 13 (2015): 1467-1474. http://www.scopus.com/inward/record.url?eid=2-s2.0-84939154897&partnerID=MN8TOARS.
  141. Pinheiro, M.; Pinto, C.; Peixoto, A.; Veiga, I.; Lopes, P.; Henrique, R.; Baldaia, H.; et al. "Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation". British Journal of Cancer 113 4 (2015): 686-692. http://www.scopus.com/inward/record.url?eid=2-s2.0-84939264921&partnerID=MN8TOARS.
  142. Davies, N.M.; Gaunt, T.R.; Lewis, S.J.; Holly, J.; Donovan, J.L.; Hamdy, F.C.; Kemp, J.P.; et al. "The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium". Cancer Causes and Control 26 11 (2015): 1603-1616. http://www.scopus.com/inward/record.url?eid=2-s2.0-84943363498&partnerID=MN8TOARS.
  143. Peixoto, A.; Santos, C.; Pinto, P.; Pinheiro, M.; Rocha, P.; Pinto, C.; Bizarro, S.; et al. "The role of targeted BRCA1/BRCA2 mutation analysis in hereditary breast/ovarian cancer families of Portuguese ancestry". Clinical Genetics 88 1 (2015): 41-48. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930416198&partnerID=MN8TOARS.
  144. Blein, S.; Bardel, C.; Danjean, V.; McGuffog, L.; Healey, S.; Barrowdale, D.; Lee, A.; et al. "An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers". Breast Cancer Research 17 1 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84932607033&partnerID=MN8TOARS.
  145. Blanco, I.; Kuchenbaecker, K.; Cuadras, D.; Wang, X.; Barrowdale, D.; De Garibay, G.R.; Librado, P.; et al. "Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers". PLoS ONE 10 4 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84927153607&partnerID=MN8TOARS.
  146. Cheng, T.H.T.; Thompson, D.; Painter, J.; Omara, T.; Gorman, M.; Martin, L.; Palles, C.; et al. "Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1". Scientific Reports 5 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84949294759&partnerID=MN8TOARS.
  147. Wu, K.; Zhang, X.; Li, F.; Xiao, D.; Hou, Y.; Zhu, S.; Liu, D.; et al. "Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas". Nature Communications 6 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84949570896&partnerID=MN8TOARS.
  148. Santos, J.; Mesquita, D.; Barros-Silva, J.D.; Jerónimo, C.; Henrique, R.; Morais, A.; Paulo, P.; et al. "Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements". Oncoscience 2 5 (2015): 497-507. http://www.scopus.com/inward/record.url?eid=2-s2.0-84958552285&partnerID=MN8TOARS.
  149. Timofeeva, M.N.; Kinnersley, B.; Farrington, S.M.; Whiffin, N.; Palles, C.; Svinti, V.; Lloyd, A.; et al. "Recurrent Coding Sequence Variation Explains only A Small Fraction of the Genetic Architecture of Colorectal Cancer". Scientific Reports 5 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84946593635&partnerID=MN8TOARS.
  150. Szulkin, R.; Karlsson, R.; Whitington, T.; Aly, M.; Gronberg, H.; Eeles, R. A.; Easton, D. F.; et al. "Genome-wide association study of prostate cancer-specific survival". Cancer Epidemiol Biomarkers Prev (2015):
  151. Mesquita, D.; Barros-Silva, J.D.; Santos, J.; Skotheim, R.I.; Lothe, R.A.; Paulo, P.; Teixeira, M.R.. Corresponding author: Teixeira, M.R.. "Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts". Oncotarget 6 7 (2015): 5217-5236. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000352792000048&KeyUID=WOS:000352792000048.
  152. Kuchenbaecker, K.B.; Ramus, S.J.; Tyrer, J.; Lee, A.; Shen, H.C.; Beesley, J.; Lawrenson, K.; et al. "Identification of six new susceptibility loci for invasive epithelial ovarian cancer". Nature Genetics 47 2 (2015): 164-171. http://www.scopus.com/inward/record.url?eid=2-s2.0-84929171835&partnerID=MN8TOARS.
  153. Kuchenbaecker, K.B.; Neuhausen, S.L.; Robson, M.; Barrowdale, D.; McGuffog, L.; Mulligan, A.M.; Andrulis, I.L.; et al. "Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers". Breast Cancer Research 16 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84928558663&partnerID=MN8TOARS.
  154. Eloy, C.; Oliveira, M.; Vieira, J.; Teixeira, M.R.; Cruz, J.; Sobrinho-Simões, M.. "Carcinoma of the thyroid with Ewing family tumor elements and favorable prognosis: Report of a second case". International Journal of Surgical Pathology 22 3 (2014): 260-265. http://www.scopus.com/inward/record.url?eid=2-s2.0-84899512365&partnerID=MN8TOARS.
  155. Osorio, A.; Milne, R.L.; Kuchenbaecker, K.; Vaclová, T.; Pita, G.; Alonso, R.; Peterlongo, P.; et al. "DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers". PLoS Genetics 10 4 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84901332067&partnerID=MN8TOARS.
  156. Camilo, V.; Barros, R.; Celestino, R.; Castro, P.; Vieira, J.; Teixeira, M.R.; Carneiro, F.; et al. "Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome". BMC Cancer 14 1 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84935505045&partnerID=MN8TOARS.
  157. Kinnersley, B.; Buch, S.; Castellví-Bel, S.; Farrington, S.M.; Forsti, A.; Hampe, J.; Hemminki, K.; et al. "Re: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis.". Journal of the National Cancer Institute 106 5 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84904061809&partnerID=MN8TOARS.
  158. Almeida, M.; Costa, V.L.; Costa, N.R.; Ramalho-Carvalho, J.; Baptista, T.; Ribeiro, F.R.; Paulo, P.; et al. "Epigenetic regulation of EFEMP1 in prostate cancer: Biological relevance and clinical potential". Journal of Cellular and Molecular Medicine 18 11 (2014): 2287-2297. http://www.scopus.com/inward/record.url?eid=2-s2.0-84911154872&partnerID=MN8TOARS.
  159. Li, Y.; Schwab, C.; Ryan, S.L.; Papaemmanuil, E.; Robinson, H.M.; Jacobs, P.; Moorman, A.V.; et al. "Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia". Nature 508 1 (2014): 98-102. http://www.scopus.com/inward/record.url?eid=2-s2.0-84897528140&partnerID=MN8TOARS.
  160. Eloy, C.; Cameselle-Teijeiro, J.; Vieira, J.; Teixeira, M.R.; Cruz, J.; Sobrinho-Simões, M.. "Carcinoma of the thyroid with Ewing/PNET family tumor elements: A tumor of unknown histogenesis". International Journal of Surgical Pathology 22 6 (2014): 579-581. http://www.scopus.com/inward/record.url?eid=2-s2.0-84906218304&partnerID=MN8TOARS.
  161. Rodriguez-Paredes, M.; Martinez De Paz, A.; Simó-Riudalbas, L.; Sayols, S.; Moutinho, C.; Moran, S.; Villanueva, A.; et al. "Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis". Oncogene 33 21 (2014): 2807-2813. http://www.scopus.com/inward/record.url?eid=2-s2.0-84901508481&partnerID=MN8TOARS.
  162. Saunders, E.J.; Dadaev, T.; Leongamornlert, D.A.; Jugurnauth-Little, S.; Tymrakiewicz, M.; Wiklund, F.; Al Olama, A.A.; et al. "Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer". PLoS Genetics 10 2 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84901741339&partnerID=MN8TOARS.
  163. Pinto, A.E.; Silva, G.L.; Henrique, R.; Menezes, F.D.; Teixeira, M.R.; Leite, V.; Cavaco, B.M.. "Familial vs sporadic papillary thyroid carcinoma: A matched-case comparative study showing similar clinical/prognostic behaviour". European Journal of Endocrinology 170 2 (2014): 321-327. http://www.scopus.com/inward/record.url?eid=2-s2.0-84893700531&partnerID=MN8TOARS.
  164. De Miranda, N.F.C.C.; Georgiou, K.; Chen, L.; Wu, C.; Gao, Z.; Zaravinos, A.; Lisboa, S.; et al. "Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients". Blood 124 16 (2014): 2544-2553. http://www.scopus.com/inward/record.url?eid=2-s2.0-84908125471&partnerID=MN8TOARS.
  165. Barroca, H.; Souto Moura, C.; Lopes, J.M.; Lisboa, S.; Teixeira, M.R.; Damasceno, M.; Bastos, P.; Sobrinho-Simões, M.. "PNET with neuroendocrine differentiation of the lung: Report of an unusual entity". International Journal of Surgical Pathology 22 5 (2014): 427-433. http://www.scopus.com/inward/record.url?eid=2-s2.0-84904760095&partnerID=MN8TOARS.
  166. Santos, C.; Peixoto, A.; Rocha, P.; Pinto, P.; Bizarro, S.; Pinheiro, M.; Pinto, C.; Henrique, R.; Teixeira, M.R.. "Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in portuguese breast/ovarian cancer families". Journal of Molecular Diagnostics 16 3 (2014): 324-334. http://www.scopus.com/inward/record.url?eid=2-s2.0-84898799068&partnerID=MN8TOARS.
  167. Sveen, A.; Johannessen, B.; Teixeira, M.R.; Lothe, R.A.; Skotheim, R.I.. "Transcriptome instability as a molecular pan-cancer characteristic of carcinomas". BMC Genomics 15 1 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84906737819&partnerID=MN8TOARS.
  168. Giacomazzi, J.; Correia, R.L.; Palmero, E.I.; Gaspar, J.F.; Almeida, M.; Portela, C.; Camey, S.A.; et al. "The Brazilian founder mutation TP53 p.R337H is uncommon in Portuguese women diagnosed with breast cancer". Breast Journal 20 5 (2014): 534-536. http://www.scopus.com/inward/record.url?eid=2-s2.0-84908136563&partnerID=MN8TOARS.
  169. Bancroft, E.K.; Page, E.C.; Castro, E.; Lilja, H.; Vickers, A.; Sjoberg, D.; Assel, M.; et al. "Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study". European Urology 66 3 (2014): 489-499. http://www.scopus.com/inward/record.url?eid=2-s2.0-84905907030&partnerID=MN8TOARS.
  170. Benson, C.; Stobie, L.; Shur, N.; Yuan, Z.; Teixeira, M.R.; Chung, M.. "After Angelina and the Supreme Court Decision, where do we go from here? BRCA gene testing in Rhode Island's Portuguese population". American Journal of Medical Genetics, Part A 164 2 (2014): 557-558. http://www.scopus.com/inward/record.url?eid=2-s2.0-84892842952&partnerID=MN8TOARS.
  171. Al Olama, A.A.; Kote-Jarai, Z.; Berndt, S.I.; Conti, D.V.; Schumacher, F.; Han, Y.; Benlloch, S.; et al. "A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer". Nature Genetics (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84922073508&partnerID=MN8TOARS.
  172. Botelho, M.C.; Veiga, I.; Oliveira, P.A.; Lopes, C.; Teixeira, M.; Correia da Costa, J.M.; Machado, J.C.. "Carcinogenic ability of Schistosoma haematobium possibly through oncogenic mutation of KRAS gene". Adv Cancer Res Treat (2013): 876585. https://pubmed.ncbi.nlm.nih.gov/25221779/.
  173. Kote-Jarai, Z; Saunders, EJ; Leongamornlert, DA; Tymrakiewicz, M; Dadaev, T; Jugurnauth-Little, S; Ross-Adams, H; et al. "Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression". Human Molecular Genetics 22 12 (2013): 2520-2528. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000319432800017&KeyUID=WOS:000319432800017.
  174. Lovf, M; Thomassen, GOS; Mertens, F; Cerveira, N; Teixeira, MR; Lothe, RA; Skotheim, RI. "Assessment of Fusion Gene Status in Sarcomas Using a Custom Made Fusion Gene Microarray". Plos One 8 8 (2013): http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000323115800010&KeyUID=WOS:000323115800010.
  175. Mesquita, B.; Lopes, P.; Rodrigues, A.; Pereira, D.; Afonso, M.; Leal, C.; Henrique, R.; et al. "Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes". Breast Cancer Research and Treatment 138 1 (2013): 37-45. http://www.scopus.com/inward/record.url?eid=2-s2.0-84874660862&partnerID=MN8TOARS.
  176. De Miranda, N.; Peng, R.; Georgiou, K.; Wu, C.; Falk Sörqvist, E.; Berglund, M.; Chen, L.; et al. "DNA repair genes are selectively mutated in diffuse large B cell lymphomas". Journal of Experimental Medicine 210 9 (2013): 1729-1742. http://www.scopus.com/inward/record.url?eid=2-s2.0-84884273290&partnerID=MN8TOARS.
  177. Patrício, P.; Ramalho-Carvalho, J.; Costa-Pinheiro, P.; Almeida, M.; Barros-Silva, J.D.; Vieira, J.; Dias, P.C.; et al. "Deregulation of PAX2 expression in renal cell tumours: Mechanisms and potential use in differential diagnosis". Journal of Cellular and Molecular Medicine 17 8 (2013): 1048-1058. http://www.scopus.com/inward/record.url?eid=2-s2.0-84888205093&partnerID=MN8TOARS.
  178. Dastugue, N.; Suciu, S.; Plat, G.; Speleman, F.; Cavé, H.; Girard, S.; Bakkus, M.; et al. "Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results.". Blood 121 13 (2013): 2415-2423. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878392379&partnerID=MN8TOARS.
  179. Guedes, J.G.; Veiga, I.; Rocha, P.; Pinto, P.; Pinto, C.; Pinheiro, M.; Peixoto, A.; et al. "High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer". BMC Cancer 13 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84875483113&partnerID=MN8TOARS.
  180. Peixoto, A.; Pinheiro, M.; Massena, L.; Santos, C.; Pinto, P.; Rocha, P.; Pinto, C.; Teixeira, M.R.. "Genomic characterization of two large Alu-mediated rearrangements of the BRCA1 gene". Journal of Human Genetics 58 2 (2013): 78-83. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875464936&partnerID=MN8TOARS.
  181. Meyer, C.; Hofmann, J.; Burmeister, T.; Gröger, D.; Park, T.S.; Emerenciano, M.; Pombo De Oliveira, M.; et al. "The MLL recombinome of acute leukemias in 2013". Leukemia 27 11 (2013): 2165-2176. http://www.scopus.com/inward/record.url?eid=2-s2.0-84887320453&partnerID=MN8TOARS.
  182. Lisboa, S.; Cerveira, N.; Bizarro, S.; Correia, C.; Vieira, J.; Torres, L.; Mariz, J.M.; Teixeira, M.R.. "POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15)". Molecular Cancer 12 1 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84872323686&partnerID=MN8TOARS.
  183. Barros-Silva, J.D.; Paulo, P.; Bakken, A.C.; Cerveira, N.; Løvf, M.; Henrique, R.; Jerónimo, C.; et al. "Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer". Neoplasia (United States) 15 7 (2013): 720-726. http://www.scopus.com/inward/record.url?eid=2-s2.0-84879632065&partnerID=MN8TOARS.
  184. Jin, Y.; Qu, S.; Tesikova, M.; Wang, L.; Kristian, A.; Mælandsmo, G.M.; Kong, H.; et al. "Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer". Proceedings of the National Academy of Sciences of the United States of America 110 28 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84879893820&partnerID=MN8TOARS.
  185. Pinheiro, M.; Pinto, C.; Peixoto, A.; Veiga, I.; Mesquita, B.; Henrique, R.; Lopes, P.; et al. "The MSH2 c.388_389del mutation shows a founder effect in Portuguese Lynch syndrome families". Clinical Genetics 84 3 (2013): 244-250. http://www.scopus.com/inward/record.url?eid=2-s2.0-84881610774&partnerID=MN8TOARS.
  186. Ramalho-Carvalho, J.; Pires, M.; Lisboa, S.; Graça, I.; Rocha, P.; Barros-Silva, J.D.; Savva-Bordalo, J.; et al. "Altered Expression of MGMT in High-Grade Gliomas Results from the Combined Effect of Epigenetic and Genetic Aberrations". PLoS ONE 8 3 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84874862608&partnerID=MN8TOARS.
  187. Al Olama, A.A.; Kote-Jarai, Z.; Schumacher, F.R.; Wiklund, F.; Berndt, S.I.; Benlloch, S.; Giles, G.G.; et al. "A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease". Human Molecular Genetics 22 2 (2013): 408-415. http://www.scopus.com/inward/record.url?eid=2-s2.0-84871603324&partnerID=MN8TOARS.
  188. Nome, T.; Thomassen, G.O.S.; Bruun, J.; Ahlquist, T.; Bakken, A.C.; Hoff, A.M.; Rognum, T.; et al. "Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing". Translational Oncology 6 5 (2013): 546-553. http://www.scopus.com/inward/record.url?eid=2-s2.0-84885716933&partnerID=MN8TOARS.
  189. Fernandez-Rozadilla, C.; Palles, C.; Carvajal-Carmona, L.; Peterlongo, P.; Nici, C.; Veneroni, S.; Pinheiro, M.; et al. "BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern european populations". Carcinogenesis 34 2 (2013): 314-318. http://www.scopus.com/inward/record.url?eid=2-s2.0-84873529797&partnerID=MN8TOARS.
  190. Eeles, R.A.; Olama, A.A.A.; Benlloch, S.; Saunders, E.J.; Leongamornlert, D.A.; Tymrakiewicz, M.; Ghoussaini, M.; et al. "Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array". Nature Genetics 45 4 (2013): 385-391. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875739291&partnerID=MN8TOARS.
  191. Kyriazoglou, A.I.; Vieira, J.; Dimitriadis, E.; Arnogiannaki, N.; Teixeira, M.R.; Pandis, N.. "12q amplification defines a subtype of extraskeletal osteosarcoma with good prognosis that is the soft tissue homologue of parosteal osteosarcoma". Cancer Genetics 205 6 (2012): 332-336. http://www.scopus.com/inward/record.url?eid=2-s2.0-84865845991&partnerID=MN8TOARS.
  192. Du, L.; Peng, R.; Björkman, A.; de Miranda, N.F.; Rosner, C.; Kotnis, A.; Berglund, M.; et al. "Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis". Journal of Experimental Medicine 209 2 (2012): 291-305. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863115243&partnerID=MN8TOARS.
  193. Leça, L.B.; Vieira, J.; Teixeira, M.R.; Monteiro, P.. "Desmoplastic small round cell tumor: Diagnosis by fine-needle aspiration cytology". Acta Cytologica 56 5 (2012): 576-580. http://www.scopus.com/inward/record.url?eid=2-s2.0-84867722545&partnerID=MN8TOARS.
  194. de Mello, R.A.; Pires, F.S.; Marques, D.S.; Oliveira, J.; Rodrigues, A.; Soares, M.; Azevedo, I.; et al. "EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study.". Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 33 6 (2012): 2061-2068. http://www.scopus.com/inward/record.url?eid=2-s2.0-85027933944&partnerID=MN8TOARS.
  195. Paulo, P.; Barros-Silva, J.D.; Ribeiro, F.R.; Ramalho-Carvalho, J.; Jerónimo, C.; Henrique, R.; Lind, G.E.; et al. "FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer". Genes Chromosomes and Cancer 51 3 (2012): 240-249. http://www.scopus.com/inward/record.url?eid=2-s2.0-84855480278&partnerID=MN8TOARS.
  196. Tomaz, R.A.; Sousa, I.; Silva, J.G.; Santos, C.; Teixeira, M.R.; Leite, V.; Cavaco, B.M.. "FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility". Clinical Endocrinology 77 6 (2012): 926-933. http://www.scopus.com/inward/record.url?eid=2-s2.0-84869040208&partnerID=MN8TOARS.
  197. Cerveira, N.; Lisboa, S.; Correia, C.; Bizarro, S.; Santos, J.; Torres, L.; Vieira, J.; et al. "Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution". Molecular Oncology 6 5 (2012): 553-564. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866023056&partnerID=MN8TOARS.
  198. Silva, A.G.; Ewald, I.P.; Sapienza, M.; Pinheiro, M.; Peixoto, A.; de Nóbrega, A.F.; Carraro, D.M.; et al. "Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion". BMC Cancer 12 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84869503925&partnerID=MN8TOARS.
  199. Paulo, P.; Ribeiro, F.R.; Santos, J.; Mesquita, D.; Almeida, M.; Barros-Silva, J.D.; Itkonen, H.; et al. "Molecular Subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements". Neoplasia (United States) 14 7 (2012): 600-611. http://www.scopus.com/inward/record.url?eid=2-s2.0-84865619515&partnerID=MN8TOARS.
  200. Moreira, M.A.M.; Bobrovnitchaia, I.G.; Lima, M.A.F.D.; Santos, A.C.E.; Ramos, J.P.; Souza, K.R.L.; Peixoto, A.; Teixeira, M.R.; Vargas, F.R.. "Portuguese c.156-157insAlu BRCA2 founder mutation: Gastrointestinal and tongue neoplasias may be part of the phenotype". Familial Cancer 11 4 (2012): 657-660. http://www.scopus.com/inward/record.url?eid=2-s2.0-84870416044&partnerID=MN8TOARS.
  201. Camões, M.J.; Paulo, P.; Ribeiro, F.R.; Barros-Silva, J.D.; Almeida, M.; Costa, V.L.; Cerveira, N.; et al. "Potential Downstream Target Genes of Aberrant ETS Transcription Factors Are Differentially Affected in Ewing's Sarcoma and Prostate Carcinoma". PLoS ONE 7 11 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84869748097&partnerID=MN8TOARS.
  202. Costa-Rodrigues, J.; Moniz, K.A.; Teixeira, M.R.; Fernandes, M.H.. "Variability of the paracrine-induced osteoclastogenesis by human breast cancer cell lines". Journal of Cellular Biochemistry 113 3 (2012): 1069-1079. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857526302&partnerID=MN8TOARS.
  203. Pinheiro, M.; Pinto, C.; Peixoto, A.; Veiga, I.; Mesquita, B.; Henrique, R.; Baptista, M.; et al. "A novel exonic rearrangement affecting MLH1 and the contiguous LRRFIP2 is a founder mutation in Portuguese Lynch syndrome families". Genetics in Medicine 13 10 (2011): 895-902. http://www.scopus.com/inward/record.url?eid=2-s2.0-80053921751&partnerID=MN8TOARS.
  204. Torres, L.; Lisboa, S.; Vieira, J.; Cerveira, N.; Santos, J.; Pinheiro, M.; Correia, C.; et al. "Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene". Pediatric Blood and Cancer 56 5 (2011): 846-849. http://www.scopus.com/inward/record.url?eid=2-s2.0-79952182934&partnerID=MN8TOARS.
  205. Pinto, P.; Rocha, P.; Veiga, I.; Guedes, J.; Pinheiro, M.; Peixoto, A.; Pinto, C.; et al. "Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer". Cancer Genetics 204 8 (2011): 439-446. http://www.scopus.com/inward/record.url?eid=2-s2.0-84856399968&partnerID=MN8TOARS.
  206. Ribeiro, F.R.; Paulo, P.; Costa, V.L.; Barros-Silva, J.D.; Ramalho-Carvalho, J.; Jerónimo, C.; Henrique, R.; et al. "Cysteine-Rich secretory protein-3 (CRISP3) is strongly Up-Regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene". PLoS ONE 6 7 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-79960632568&partnerID=MN8TOARS.
  207. Bartosch, C.; Vieira, J.; Teixeira, M.R.; Lopes, J.M.. "Endometrial endometrioid adenocarcinoma associated with primitive neuroectodermal tumour of the uterus: A poor prognostic subtype of uterine tumours". Medical Oncology 28 4 (2011): 1488-1494. http://www.scopus.com/inward/record.url?eid=2-s2.0-84655170298&partnerID=MN8TOARS.
  208. Peixoto, A.; Santos, C.; Pinheiro, M.; Pinto, P.; Soares, M.J.; Rocha, P.; Gusmão, L.; et al. "International distribution and age estimation of the Portuguese BRCA2 c.156-157insAlu founder mutation". Breast Cancer Research and Treatment 127 3 (2011): 671-679. http://www.scopus.com/inward/record.url?eid=2-s2.0-79958280483&partnerID=MN8TOARS.
  209. Lestre, S.; João, A.; Ponte, P.; Peixoto, A.; Vieira, J.; Teixeira, M.R.; Fidalgo, A.. "Intraepidermal epidermotropic metastatic melanoma: A clinical and histopathological mimicker of melanoma in situ occurring in multiplicity". Journal of Cutaneous Pathology 38 6 (2011): 514-520. http://www.scopus.com/inward/record.url?eid=2-s2.0-79955525974&partnerID=MN8TOARS.
  210. Cerveira, N.; Bizarro, S.; Teixeira, M.R.. "MLL-SEPTIN gene fusions in hematological malignancies". Biological Chemistry 392 8-9 (2011): 713-724. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052784488&partnerID=MN8TOARS.
  211. Barros-Silva, J.D.; Ribeiro, F.R.; Rodrigues, Â.; Cruz, R.; Martins, A.T.; Jerónimo, C.; Henrique, R.; Teixeira, M.R.. "Relative 8q gain predicts disease-specific survival irrespective of the TMPRSS2-ERG fusion status in diagnostic biopsies of prostate cancer". Genes Chromosomes and Cancer 50 8 (2011): 662-671. http://www.scopus.com/inward/record.url?eid=2-s2.0-79958025241&partnerID=MN8TOARS.
  212. Costa, V.L.; Henrique, R.; Danielsen, S.A.; Eknaes, M.; Patrício, P.; Morais, A.; Oliveira, J.; et al. "TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers". Epigenetics 6 9 (2011): 1120-1130. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052585520&partnerID=MN8TOARS.
  213. Cerveira, N.; Meyer, C.; Santos, J.; Torres, L.; Lisboa, S.; Pinheiro, M.; Bizarro, S.; et al. "A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia". BMC Cancer 10 (2010): http://www.scopus.com/inward/record.url?eid=2-s2.0-77957153936&partnerID=MN8TOARS.
  214. Silva, M.; Veiga, I.; Ribeiro, F.R.; Vieira, J.; Pinto, C.; Pinheiro, M.; Mesquita, B.; et al. "Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors". BMC Medicine 8 (2010): http://www.scopus.com/inward/record.url?eid=2-s2.0-77952062243&partnerID=MN8TOARS.
  215. Santos, J.; Cerveira, N.; Correia, C.; Lisboa, S.; Pinheiro, M.; Torres, L.; Bizarro, S.; et al. "Coexistence of alternative MLL-SEPT9 fusion transcripts in an acute myeloid leukemia with t(11;17)(q23;q25)". Cancer Genetics and Cytogenetics 197 1 (2010): 60-64. http://www.scopus.com/inward/record.url?eid=2-s2.0-74749098831&partnerID=MN8TOARS.
  216. Pinheiro, M.; Ahlquist, T.; Danielsen, S.A.; Lind, G.E.; Veiga, I.; Pinto, C.; Costa, V.; et al. "Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin.". BMC cancer 10 (2010): http://www.scopus.com/inward/record.url?eid=2-s2.0-77958501860&partnerID=MN8TOARS.
  217. Carvalho, J.R.; Filipe, L.; Costa, V.L.; Ribeiro, F.R.; Martins, A.T.; Teixeira, M.R.; Jerónimo, C.; Henrique, R.. "Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer". Apoptosis 15 8 (2010): 956-965. http://www.scopus.com/inward/record.url?eid=2-s2.0-77956905086&partnerID=MN8TOARS.
  218. Berg, M.; Ågesen, T.H.; Thiis-Evensen, E.; Merok, M.A.; Teixeira, M.R.; Vatn, M.H.; Nesbakken, A.; Skotheim, R.I.; Lothe, R.A.. "Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci". Molecular Cancer 9 (2010): http://www.scopus.com/inward/record.url?eid=2-s2.0-77951811915&partnerID=MN8TOARS.
  219. Costa, V.L.; Henrique, R.; Ribeiro, F.R.; Carvalho, J.R.; Oliveira, J.; Lobo, F.; Teixeira, M.R.; Jerónimo, C.. "Epigenetic regulation of Wnt signaling pathway in urological cancer". Epigenetics 5 4 (2010): 343-351. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954662435&partnerID=MN8TOARS.
  220. Santos, J.; Cerveira, N.; Bizarro, S.; Ribeiro, F.R.; Correia, C.; Torres, L.; Lisboa, S.; et al. "Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes". Leukemia Research 34 5 (2010): 615-621. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950071392&partnerID=MN8TOARS.
  221. Vieira, J.; Henrique, R.; Ribeiro, F.R.; Barros-Silva, J.D.; Peixoto, A.; Santos, C.; Pinheiro, M.; et al. "Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies". Genes Chromosomes and Cancer 49 10 (2010): 935-947. http://www.scopus.com/inward/record.url?eid=2-s2.0-77957877009&partnerID=MN8TOARS.
  222. Brekke, H.R.; Ribeiro, F.R.; Kolberg, M.; Ågesen, T.H.; Lind, G.E.; Eknæs, M.; Hall, K.S.; et al. "Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group". Journal of Clinical Oncology 28 9 (2010): 1573-1582. http://www.scopus.com/inward/record.url?eid=2-s2.0-77951904713&partnerID=MN8TOARS.
  223. Brandal, P.; Teixeira, M.R.; Heim, S.. "Genotypic and phenotypic classification of cancer: How should the impact of the two diagnostic approaches best be balanced?". Genes Chromosomes and Cancer 49 9 (2010): 763-774. http://www.scopus.com/inward/record.url?eid=2-s2.0-77955506634&partnerID=MN8TOARS.
  224. Veiga, I.; Silva, M.; Vieira, J.; Pinto, C.; Pinheiro, M.; Torres, L.; Soares, M.; et al. "Hereditary gastrointestinal stromal tumors sharing the KIT exon 17 germline mutation p.Asp820Tyr develop through different cytogenetic progression pathways". Genes Chromosomes and Cancer 49 2 (2010): 91-98. http://www.scopus.com/inward/record.url?eid=2-s2.0-75149193619&partnerID=MN8TOARS.
  225. Savva-Bordalo, J.; Ramalho-Carvalho, J.; Pinheiro, M.; Costa, V.L.; Rodrigues, T.; Dias, P.C.; Veiga, I.; et al. "Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients". BMC Cancer 10 (2010): http://www.scopus.com/inward/record.url?eid=2-s2.0-77956472030&partnerID=MN8TOARS.
  226. Costa, V.L.; Henrique, R.; Danielsen, S.A.; Duarte-Pereira, S.; Eknaes, M.; Skotheim, R.I.; Rodrigues, Â.; et al. "Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples". Clinical Cancer Research 16 23 (2010): 5842-5851. http://www.scopus.com/inward/record.url?eid=2-s2.0-78650354147&partnerID=MN8TOARS.
  227. Peixoto, A.; Santos, C.; Rocha, P.; Pinheiro, M.; Príncipe, S.; Pereira, D.; Rodrigues, H.; et al. "The c.156-157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal". Breast Cancer Research and Treatment 114 1 (2009): 31-38. http://www.scopus.com/inward/record.url?eid=2-s2.0-58849092856&partnerID=MN8TOARS.
  228. Pinto, C.; Veiga, I.; Pinheiro, M.; Peixoto, A.; Pinto, A.; Lopes, J.M.; Reis, R.M.; et al. "TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset". Familial Cancer 8 4 (2009): 383-390. http://www.scopus.com/inward/record.url?eid=2-s2.0-70449519172&partnerID=MN8TOARS.
  229. Skotheim, R.I.; Thomassen, G.O.S.; Eken, M.; Lind, G.E.; Micci, F.; Ribeiro, F.R.; Cerveira, N.; et al. "A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis". Molecular Cancer 8 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-60649100664&partnerID=MN8TOARS.
  230. Barroca, H.; Castedo, S.; Vieira, J.; Teixeira, M.; Müller-Höcker, J.. "Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation". Pathology Research and Practice 205 7 (2009): 466-472. http://www.scopus.com/inward/record.url?eid=2-s2.0-67349099168&partnerID=MN8TOARS.
  231. Barros-Silva, J.D.; Leit~o, D.; Afonso, L.; Vieira, J.; Dinis-Ribeiro, M.; Fragoso, M.; Bento, M.J.; et al. "Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients". British Journal of Cancer 100 3 (2009): 487-493. http://www.scopus.com/inward/record.url?eid=2-s2.0-59649084142&partnerID=MN8TOARS.
  232. Cerveira, N.; Santos, J.; Bizarro, S.; Costa, V.; Ribeiro, F.R.; Lisboa, S.; Correia, C.; et al. "Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia". BMC Cancer 9 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-66949157646&partnerID=MN8TOARS.
  233. Soares, M.J.; Pinto, M.; Henrique, R.; Vieira, J.; Cerveira, N.; Peixoto, A.; Martins, A.T.; et al. "CSF1R copy number changes, point mutations, and RNA and protein overexpression in renal cell carcinomas". Modern Pathology 22 6 (2009): 744-752. http://www.scopus.com/inward/record.url?eid=2-s2.0-67349179639&partnerID=MN8TOARS.
  234. Santos, C.; Peixoto, A.; Rocha, P.; Vega, A.; Soares, M.J.; Cerveira, N.; Bizarro, S.; et al. "Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin". Familial Cancer 8 3 (2009): 203-208. http://www.scopus.com/inward/record.url?eid=2-s2.0-68449087758&partnerID=MN8TOARS.
  235. Pinheiro, M.; Veiga, I.; Pinto, C.; Afonso, L.; Sousa, O.; Fragoso, M.; Santos, L.; et al. "Mitochondrial genome alterations in rectal and sigmoid carcinomas". Cancer Letters 280 1 (2009): 38-43. http://www.scopus.com/inward/record.url?eid=2-s2.0-67349130194&partnerID=MN8TOARS.
  236. Peixoto, A.; Santos, C.; Rocha, P.; Pinto, P.; Bizarro, S.; Teixeira, M.R.. "Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156-157insAlu". Breast Cancer Research and Treatment 117 1 (2009): 215-217. http://www.scopus.com/inward/record.url?eid=2-s2.0-69049087994&partnerID=MN8TOARS.
  237. Teixeira, M.R.. "Multiple numerical chromosome aberrations in carcinogenesis: The kidney cancer model". Cellular Oncology 31 1 (2009): 57-59. http://www.scopus.com/inward/record.url?eid=2-s2.0-58149380015&partnerID=MN8TOARS.
  238. Teixeira, M.R.; Cerveira, N.; Santos, J.. "Structural and expression changes of septins in myeloid neoplasia.". Critical reviews in oncogenesis 15 1-2 (2009): 91-115. http://www.scopus.com/inward/record.url?eid=2-s2.0-77951227386&partnerID=MN8TOARS.
  239. Torres, L.; Lisboa, S.; Cerveira, N.; Lopes, J.M.; Lopes, C.; Teixeira, M.R.. "Cryptic chromosome rearrangement resulting in SYT-SSX2 fusion gene in a monophasic synovial sarcoma". Cancer Genetics and Cytogenetics 187 1 (2008): 45-49. http://www.scopus.com/inward/record.url?eid=2-s2.0-55149109459&partnerID=MN8TOARS.
  240. Lisboa, S.; Cerveira, N.; Vieira, J.; Torres, L.; Ferreira, A.M.; Afonso, M.; Norton, L.; Henrique, R.; Teixeira, M.R.. "Genetic diagnosis of alveolar rhabdomyosarcoma in the bone marrow of a patient without evidence of primary tumor". Pediatric Blood and Cancer 51 4 (2008): 554-557. http://www.scopus.com/inward/record.url?eid=2-s2.0-50249120037&partnerID=MN8TOARS.
  241. Hallor, K.H.; Teixeira, M.R.; Fletcher, C.D.M.; Bizarro, S.; Staaf, J.; Domanski, H.A.; Von Steyern, F.V.; et al. "Heterogeneous genetic profiles in soft tissue myoepitheliomas". Modern Pathology 21 11 (2008): 1311-1319. http://www.scopus.com/inward/record.url?eid=2-s2.0-57749108339&partnerID=MN8TOARS.
  242. Cerveira, N.; Micci, F.; Santos, J.; Pinheiro, M.; Correia, C.; Lisboa, S.; Bizarro, S.; et al. "Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: Identification of novel fusion transcripts and cloning of Genomic breakpoint junctions". Haematologica 93 7 (2008): 1076-1080. http://www.scopus.com/inward/record.url?eid=2-s2.0-46849083097&partnerID=MN8TOARS.
  243. Pinto, M.; Vieira, J.; Ribeiro, F.R.; Soares, M.J.; Henrique, R.; Oliveira, J.; Jerónimo, C.; Teixeira, M.R.. "Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas". Cellular Oncology 30 5 (2008): 389-395. http://www.scopus.com/inward/record.url?eid=2-s2.0-52449130697&partnerID=MN8TOARS.
  244. Jeronimo, C.; Monteiro, P.; Henrique, R.; Dinis-Ribeiro, M.; Costa, I.; Costa, V.L.; Filipe, L.; et al. "Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions". Breast Cancer Research and Treatment 109 1 (2008): 27-34. http://www.scopus.com/inward/record.url?eid=2-s2.0-42149087728&partnerID=MN8TOARS.
  245. Cerveira, N.; Santos, J.; Pinheiro, M.; Snijder, S.; van der Lelie, H.; Mellink, C.H.; Teixeira, M.R.. "A novel MLL-SEPT2 fusion variant in therapy-related myelodysplastic syndrome.". Cancer genetics and cytogenetics 185 1 (2008): 62-64. http://www.scopus.com/inward/record.url?eid=2-s2.0-49249108513&partnerID=MN8TOARS.
  246. Ferreira, B.I.; Alonso, J.; Carrillo, J.; Acquadro, F.; Largo, C.; Suela, J.; Teixeira, M.R.; et al. "Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma". Oncogene 27 14 (2008): 2084-2090. http://www.scopus.com/inward/record.url?eid=2-s2.0-41149168760&partnerID=MN8TOARS.
  247. Teixeira, M.R.. "Chromosome mechanisms giving rise to the TMPRSS2-ERG fusion oncogene in prostate cancer and HGPIN lesions". American Journal of Surgical Pathology 32 4 (2008): 642-644. http://www.scopus.com/inward/record.url?eid=2-s2.0-41449115193&partnerID=MN8TOARS.
  248. Ribeiro, F.R.; Meireles, A.M.; Rocha, A.S.; Teixeira, M.R.. "Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: Characterization of eight cell line models and review of the literature on clinical samples". BMC Cancer 8 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-62349094458&partnerID=MN8TOARS.
  249. Pinto, M.; Soares, M.J.; Cerveira, N.; Henrique, R.; Ribeiro, F.R.; Oliveira, J.; Jerónimo, C.; Teixeira, M.R.. "Expression changes of the MAD mitotic checkpoint gene family in renal cell carcinomas characterized by numerical chromosome changes". Virchows Archiv 450 4 (2007): 379-385. http://www.scopus.com/inward/record.url?eid=2-s2.0-33947523032&partnerID=MN8TOARS.
  250. Henrique, R.; Ribeiro, F.R.; Fonseca, D.; Hoque, M.O.; Carvalho, A.L.; Costa, V.L.; Pinto, M.; et al. "High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients". Clinical Cancer Research 13 20 (2007): 6122-6129. http://www.scopus.com/inward/record.url?eid=2-s2.0-35948929442&partnerID=MN8TOARS.
  251. Torres, L.; Ribeiro, F.R.; Pandis, N.; Andersen, J.A.; Heim, S.; Teixeira, M.R.. "Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases". Breast Cancer Research and Treatment 102 2 (2007): 143-155. http://www.scopus.com/inward/record.url?eid=2-s2.0-33947385421&partnerID=MN8TOARS.
  252. Bizarro, S.; Cerveira, N.; Correia, C.; Lisboa, S.; Peixoto, A.; Norton, L.; Teixeira, M.R.. "Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia". Cancer Genetics and Cytogenetics 178 1 (2007): 61-64. http://www.scopus.com/inward/record.url?eid=2-s2.0-34548688432&partnerID=MN8TOARS.
  253. Costa, V.L.; Henrique, R.; Ribeiro, F.R.; Pinto, M.; Oliveira, J.; Lobo, F.; Teixeira, M.R.; Jerónimo, C.. "Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors". BMC Cancer 7 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-34547779010&partnerID=MN8TOARS.
  254. Ribeiro, F.R.; Henrique, R.; Martins, A.T.; Jerónimo, C.; Teixeira, M.R.. "Relative Copy Number Gain of MYC in Diagnostic Needle Biopsies is an Independent Prognostic Factor for Prostate Cancer Patients". European Urology 52 1 (2007): 116-125. http://www.scopus.com/inward/record.url?eid=2-s2.0-34249039594&partnerID=MN8TOARS.
  255. Ribeiro, F.R.; Teixeira, M.R.. "Reply to AnnaMaria Cianciulli, Roberta Merola and Costantino Leonardo's Letter to the Editor re: Franclim R. Ribeiro, Rui Henrique, Ana T. Martins, Carmen Jerónimo and Manuel R. Teixeira. Relative Copy Number Gain of MYC in Diagnostic Needle Biopsies is an Independent Prognostic Factor for Prostate Cancer Patients. Eur Urol 2007;52:116-25". European Urology 52 5 (2007): 1539-1540. http://www.scopus.com/inward/record.url?eid=2-s2.0-34548857052&partnerID=MN8TOARS.
  256. Ribeiro, F.R.; Jerónimo, C.; Henrique, R.; Fonseca, D.; Oliveira, J.; Lothe, R.A.; Teixeira, M.R.. "8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects". Clinical Cancer Research 12 13 (2006): 3961-3970. http://www.scopus.com/inward/record.url?eid=2-s2.0-33746055324&partnerID=MN8TOARS.
  257. Lind, G.E.; Kleivi, K.; Meling, G.I.; Teixeira, M.R.; Thiis-Evensen, E.; Rognum, T.O.; Lothe, R.A.. "ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis". Cellular Oncology 28 5-6 (2006): 259-272. http://www.scopus.com/inward/record.url?eid=2-s2.0-33845679095&partnerID=MN8TOARS.
  258. Peixoto, A.; Salgueiro, N.; Santos, C.; Varzim, G.; Rocha, P.; Soares, M.J.; Pereira, D.; et al. "BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families". Familial Cancer 5 4 (2006): 379-387. http://www.scopus.com/inward/record.url?eid=2-s2.0-33845528114&partnerID=MN8TOARS.
  259. Tsarouha, H.; Kyriazoglou, A.I.; Ribeiro, F.R.; Teixeira, M.R.; Agnantis, N.; Pandis, N.. "Chromosome analysis and molecular cytogenetic investigations of an epithelioid hemangioendothelioma". Cancer Genetics and Cytogenetics 169 2 (2006): 164-168. http://www.scopus.com/inward/record.url?eid=2-s2.0-33747870517&partnerID=MN8TOARS.
  260. Ribeiro, F.R.; Henrique, R.; Hektoen, M.; Berg, M.; Jerónimo, C.; Teixeira, M.R.; Lothe, R.A.. "Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas". Molecular Cancer 5 (2006): http://www.scopus.com/inward/record.url?eid=2-s2.0-33748968523&partnerID=MN8TOARS.
  261. Henrique, R.; Jerónimo, C.; Teixeira, M.R.; Hoque, M.O.; Carvalho, A.L.; Pais, I.; Ribeiro, F.R.; et al. "Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: Clues for clonal progression in prostate carcinogenesis". Molecular Cancer Research 4 1 (2006): 1-8. http://www.scopus.com/inward/record.url?eid=2-s2.0-32944480348&partnerID=MN8TOARS.
  262. Henrique, R.; Costa, V.L.; Cerveira, N.; Carvalho, A.L.; Hoque, M.O.; Ribeiro, F.R.; Oliveira, J.; et al. "Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer". Journal of Molecular Medicine 84 11 (2006): 911-918. http://www.scopus.com/inward/record.url?eid=2-s2.0-33750435596&partnerID=MN8TOARS.
  263. Pinto, C.; Veiga, I.; Pinheiro, M.; Mesquita, B.; Jerónimo, C.; Sousa, O.; Fragoso, M.; et al. "MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease". British Journal of Cancer 95 6 (2006): 752-756. http://www.scopus.com/inward/record.url?eid=2-s2.0-33748565629&partnerID=MN8TOARS.
  264. Teixeira, M.R.. "Recurrent fusion oncogenes in carcinomas". Critical Reviews in Oncogenesis 12 3-4 (2006): 257-271. http://www.scopus.com/inward/record.url?eid=2-s2.0-34047128024&partnerID=MN8TOARS.
  265. Cerveira, N.; Correia, C.; Bizarro, S.; Pinto, C.; Lisboa, S.; Mariz, J.M.; Marques, M.; Teixeira, M.R.. "SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23)". Oncogene 25 45 (2006): 6147-6152. http://www.scopus.com/inward/record.url?eid=2-s2.0-33749836689&partnerID=MN8TOARS.
  266. Ribeiro, F.R.; Diep, C.B.; Jerónimo, C.; Henrique, R.; Lopes, C.; Eknæs, M.; Lingjærde, O.C.; Lothe, R.A.; Teixeira, M.R.. "Statistical dissection of genetic pathways involved in prostate carcinogenesis". Genes Chromosomes and Cancer 45 2 (2006): 154-163. http://www.scopus.com/inward/record.url?eid=2-s2.0-31944449020&partnerID=MN8TOARS.
  267. Diep, C.B.; Kleivi, K.; Ribeiro, F.R.; Teixeira, M.R.; Lindgjærde, O.C.; Lothe, R.A.. "The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes". Genes Chromosomes and Cancer 45 1 (2006): 31-41. http://www.scopus.com/inward/record.url?eid=2-s2.0-33644885017&partnerID=MN8TOARS.
  268. Cerveira, N.; Ribeiro, F.R.; Peixoto, A.; Costa, V.; Henrique, R.; Jerónimo, C.; Teixeira, M.R.. "TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions". Neoplasia 8 10 (2006): 826-832. http://www.scopus.com/inward/record.url?eid=2-s2.0-33749870551&partnerID=MN8TOARS.
  269. Henrique, R.; Jerónimo, C.; Hoque, M.O.; Carvalho, A.L.; Oliveira, J.; Teixeira, M.R.; Lopes, C.; Sidransky, D.. "Frequent 14-3-3s promoter methylation in benign and malignant prostate lesions". DNA and Cell Biology 24 4 (2005): 264-269. http://www.scopus.com/inward/record.url?eid=2-s2.0-16844374138&partnerID=MN8TOARS.
  270. Henrique, R.; Jerónimo, C.; Hoque, M.O.; Nomoto, S.; Carvalho, A.L.; Costa, V.L.; Oliveira, J.; et al. "MT1G hypermethylation is associated with higher tumor stage in prostate cancer". Cancer Epidemiology Biomarkers and Prevention 14 5 (2005): 1274-1278. http://www.scopus.com/inward/record.url?eid=2-s2.0-20844459807&partnerID=MN8TOARS.
  271. Cerveira, N.; Torres, L.; Ribeiro, F.R.; Henrique, R.; Pinto, A.; Bizarro, S.; Ferreira, A.M.; Lopes, C.; Teixeira, M.R.. "Multimodal genetic diagnosis of solid variant alveolar rhabdomyosarcoma". Cancer Genetics and Cytogenetics 163 2 (2005): 138-143. http://www.scopus.com/inward/record.url?eid=2-s2.0-28744456471&partnerID=MN8TOARS.
  272. Teixeira, M.R.; Heim, S.. "Multiple numerical chromosome aberrations in cancer: What are their causes and what are their consequences?". Seminars in Cancer Biology 15 1 (2005): 3-12. http://www.scopus.com/inward/record.url?eid=2-s2.0-10944219726&partnerID=MN8TOARS.
  273. Mesquita, B.; Veiga, I.; Pereira, D.; Tavares, A.; Pinto, I.M.; Pinto, C.; Teixeira, M.R.; Castedo, S.. "No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin". BMC Cancer 5 (2005): http://www.scopus.com/inward/record.url?eid=2-s2.0-26844480242&partnerID=MN8TOARS.
  274. Modena, P.; Lualdi, E.; Facchinetti, F.; Galli, L.; Teixeira, M.R.; Pilotti, S.; Sozzi, G.. "SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas". Cancer Research 65 10 (2005): 4012-4019. http://www.scopus.com/inward/record.url?eid=2-s2.0-20144386270&partnerID=MN8TOARS.
  275. Lind, G.E.; Skotheim, R.I.; Fraga, M.F.; Abeler, V.M.; Henrique, R.; Saatcioglu, F.; Esteller, M.; Teixeira, M.R.; Lothe, R.A.. "The loss of NKX3.1 expression in testicular - And prostate - Cancers is not caused by promoter hypermethylation". Molecular Cancer 4 (2005): http://www.scopus.com/inward/record.url?eid=2-s2.0-13644259352&partnerID=MN8TOARS.
  276. Kleivi, K.; Diep, C.B.; Pandis, N.; Heim, S.; Teixeira, M.R.; Lothe, R.A.. "TP53 mutations are associated with a particular pattern of genomic imbalances in breast carcinomas". Journal of Pathology 207 1 (2005): 14-19. http://www.scopus.com/inward/record.url?eid=2-s2.0-23944504305&partnerID=MN8TOARS.
  277. Castro, P.; Eknæs, M.; Teixeira, M.R.; Danielsen, H.E.; Soares, P.; Lothe, R.A.; Sobrinho-Simoões, M.. "Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes". Journal of Pathology 206 3 (2005): 305-311. http://www.scopus.com/inward/record.url?eid=2-s2.0-21344452129&partnerID=MN8TOARS.
  278. Jerónimo, C.; Henrique, R.; Hoque, M.O.; Mambo, E.; Ribeiro, F.R.; Varzim, G.; Oliveira, J.; et al. "A quantitative promoter methylation profile of prostate cancer". Clinical Cancer Research 10 24 (2004): 8472-8478. http://www.scopus.com/inward/record.url?eid=2-s2.0-19944429845&partnerID=MN8TOARS.
  279. Jerónimo, C.; Henrique, R.; Oliveira, J.; Lobo, F.; Pais, I.; Teixeira, M.R.; Lopes, C.. "Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer". Journal of Clinical Pathology 57 8 (2004): 872-876. http://www.scopus.com/inward/record.url?eid=2-s2.0-4043078431&partnerID=MN8TOARS.
  280. Teixeira, M.R.; Ribeiro, F.R.; Torres, L.; Pandis, N.; Andersen, J.A.; Lothe, R.A.; Heim, S.. "Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis". British Journal of Cancer 91 4 (2004): 775-782. http://www.scopus.com/inward/record.url?eid=2-s2.0-4344713690&partnerID=MN8TOARS.
  281. Monteiro, E.; Varzim, G.; Pires, A.M.; Teixeira, M.; Lopes, C.. "Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: Implications of tumor localization and tobacco exposure". Cancer Detection and Prevention 28 4 (2004): 237-243. http://www.scopus.com/inward/record.url?eid=2-s2.0-12344308940&partnerID=MN8TOARS.
  282. Oliveira, C.; Westra, J.L.; Arango, D.; Ollikainen, M.; Domingo, E.; Ferreira, A.; Velho, S.; et al. "Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status". Human Molecular Genetics 13 19 (2004): 2303-2311. http://www.scopus.com/inward/record.url?eid=2-s2.0-5444224121&partnerID=MN8TOARS.
  283. Diep, C.B.; Teixeira, M.R.; Thorstensen, L.; Wiig, J.N.; Eknæs, M.; Nesland, J.M.; Giercksky, K.-E.; Johansson, B.; Lothe, R.A.. "Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients". Molecular Cancer 3 (2004): http://www.scopus.com/inward/record.url?eid=2-s2.0-2942616982&partnerID=MN8TOARS.
  284. Kleivi, K.; Teixeira, M.R.; Eknæs, M.; Diep, C.B.; Jakobsen, K.S.; Hamelin, R.; Lothe, R.A.. "Genome signatures of colon carcinoma cell lines". Cancer Genetics and Cytogenetics 155 2 (2004): 119-131. http://www.scopus.com/inward/record.url?eid=2-s2.0-9644295665&partnerID=MN8TOARS.
  285. Micci, F.; Teixeira, M.R.; Haugom, L.; Kristensen, G.; Abeler, V.H.; Heim, S.. "Genomic aberrations in carcinomas of the uterine corpus". Genes Chromosomes and Cancer 40 3 (2004): 229-246. http://www.scopus.com/inward/record.url?eid=2-s2.0-2542619821&partnerID=MN8TOARS.
  286. Teixeira, M.R.; Ribeiro, F.R.; Eknæs, M.; Wæhre, H.; Stenwig, A.E.; Giercksky, K.E.; Heim, S.; Lothe, R.A.. "Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making". Cancer 101 8 (2004): 1786-1793. http://www.scopus.com/inward/record.url?eid=2-s2.0-4744361816&partnerID=MN8TOARS.
  287. Cerveira, N.; Torres, L.; Rocha, P.; Bizarro, S.; Pereira, D.; Abreu, J.; Henrique, R.; Teixeira, M.R.; Castedo, S.. "Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients". International Journal of Cancer 108 4 (2004): 592-595. http://www.scopus.com/inward/record.url?eid=2-s2.0-0348048477&partnerID=MN8TOARS.
  288. Lualdi, E.; Modena, P.; Debiec-Rychter, M.; Pedeutour, F.; Teixeira, M.R.; Facchinetti, F.; Dagrada, G.P.; Pilotti, S.; Sozzi, G.. "Molecular cytogenetic characterization of proximal-type epithelioid sarcoma". Genes Chromosomes and Cancer 41 3 (2004): 283-290. http://www.scopus.com/inward/record.url?eid=2-s2.0-4644309912&partnerID=MN8TOARS.
  289. Salgueiro, N.; Veiga, I.; Fragoso, M.; Sousa, O.; Costa, N.; Pellon, M.L.; Sanches, E.; et al. "Mutations in exon 14 of dihydropyrimidine dehydrogenase and S-Fluorouracil toxicity in Portuguese collorectal cancer patients". Genetics in Medicine 6 2 (2004): 102-107. http://www.scopus.com/inward/record.url?eid=2-s2.0-11144355814&partnerID=MN8TOARS.
  290. Jerónimo, C.; Henrique, R.; Hoque, M.O.; Ribeiro, F.R.; Oliveira, J.; Fonseca, D.; Teixeira, M.R.; Lopes, C.; Sidransky, D.. "Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker.". Clinical cancer research : an official journal of the American Association for Cancer Research 10 12 Pt 1 (2004): 4010-4014. http://www.scopus.com/inward/record.url?eid=2-s2.0-16544372387&partnerID=MN8TOARS.
  291. Papadopoulou, A.; Trangas, T.; Teixeira, M.R.; Heim, S.; Dimitriadis, E.; Tsarouha, H.; Andersen, J.A.; et al. "Telomerase activity and genetic alterations in primary breast carcinomas". Neoplasia 5 2 (2003): 170-178. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037352353&partnerID=MN8TOARS.
  292. Ioannidis, P.; Mahaira, L.; Papadopoulou, A.; Teixeira, M.R.; Heim, S.; Andersen, J.A.; Evangelou, E.; et al. "8q24 copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas". International Journal of Cancer 104 1 (2003): 54-59. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037430255&partnerID=MN8TOARS.
  293. Ioannidis, P.; Mahaira, L.; Papadopoulou, A.; Teixeira, M.R.; Heim, S.; Andersen, J.A.; Evangelou, E.; et al. "CRD-BP: A c-myc mRNA stabilizing protein with an oncofetal pattern of expression". Anticancer Research 23 3 A (2003): 2179-2183. http://www.scopus.com/inward/record.url?eid=2-s2.0-0042807286&partnerID=MN8TOARS.
  294. Micci, F.; Walter, C.U.; Teixeira, M.R.; Panagopoulos, I.; Bjerkehagen, B.; Sæter, G.; Heim, S.. "Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: Nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17)". Cancer Genetics and Cytogenetics 144 2 (2003): 119-124. http://www.scopus.com/inward/record.url?eid=2-s2.0-0038016605&partnerID=MN8TOARS.
  295. Micci, F.; Teixeira, M.R.; Scheistrøen, M.; Abeler, V.M.; Heim, S.. "Cytogenetic characterization of tumors of the vulva and vagina". Genes Chromosomes and Cancer 38 2 (2003): 137-148. http://www.scopus.com/inward/record.url?eid=2-s2.0-0041332883&partnerID=MN8TOARS.
  296. Jerónimo, C.; Costa, I.; Conceição Martins, M.; Monteiro, P.; Lisboa, S.; Palmeira, C.; Henrique, R.; Teixeira, M.R.; Lopes, C.. "Detection of gene promoter hypermethylation in fine needle washings from breast lesions". Clinical Cancer Research 9 9 (2003): 3413-3417. http://www.scopus.com/inward/record.url?eid=2-s2.0-0042334827&partnerID=MN8TOARS.
  297. Cerveira, N.; Correia, C.; Dória, S.; Bizarro, S.; Rocha, P.; Gomes, P.; Torres, L.; et al. "Frequency of NUP98-NSD1 fusion transcript in childhood acute myeloid leukaemia [7]". Leukemia 17 11 (2003): 2244-2247. http://www.scopus.com/inward/record.url?eid=2-s2.0-10744231835&partnerID=MN8TOARS.
  298. Diep, C.B.; Parada, L.A.; Teixeira, M.R.; Eknæs, M.; Nesland, J.M.; Johansson, B.; Lothe, R.A.. "Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis". Genes Chromosomes and Cancer 36 2 (2003): 189-197. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037299471&partnerID=MN8TOARS.
  299. Teixeira, M.R.; Ribeiro, F.R.; Cerveira, N.; Torres, L.; Amaro, T.; Henrique, R.; Lopes, C.. "Karyotypic divergence and convergence in two synchronous lung metastases of a clear cell sarcoma of tendons and aponeuroses with t(12;22)(q13;q12) and type 1 EWS/ATF1". Cancer Genetics and Cytogenetics 145 2 (2003): 121-125. http://www.scopus.com/inward/record.url?eid=2-s2.0-0043165097&partnerID=MN8TOARS.
  300. Teixeira, M.R.; Pandis, N.; Heim, S.; Middleton, L.P.; Eva Singletary, S.; Sahin, A.A.. "Multicentric mammary carcinoma: Evidence of monoclonal proliferation [2] (multiple letters)". Cancer 97 3 (2003): 715-717. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037303495&partnerID=MN8TOARS.
  301. Micci, F.; Teixeira, M.R.; Bjerkehagen, B.; Heim, S.. "Characterization of supernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding, CGH, M-FISH, and chromosome- and locus-specific FISH". Cytogenetic and Genome Research 97 1-2 (2002): 13-19. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036052032&partnerID=MN8TOARS.
  302. Teixeira, M.R. "Combined classical and molecular cytogenetic analysis of cancer". European Journal of Cancer 38 12 (2002): 1580-1584. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036342487&partnerID=MN8TOARS.
  303. Teixeira, M.R.; Pandis, N.; Heim, S.. "Cytogenetic clues to breast carcinogenesis". Genes Chromosomes and Cancer 33 1 (2002): 1-16. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036131935&partnerID=MN8TOARS.
  304. Kleivi, K.; Lothe, R.A.; Heim, S.; Tsarouha, H.; Kraggerud, S.M.; Pandis, N.; Papadopoulou, A.; et al. "Genome profiling of breast cancer cells selected against in vitro shows copy number changes". Genes Chromosomes and Cancer 33 3 (2002): 304-309. http://www.scopus.com/inward/record.url?eid=2-s2.0-18244395111&partnerID=MN8TOARS.
  305. Heim, S.; Teixeira, M.A.R.; Pandis, N.. "Are some breast carcinomas polyclonal in origin?". Journal of Pathology 194 4 (2001): 395-397. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034869244&partnerID=MN8TOARS.
  306. Micci, F.; Teixeira, M.R.; Heim, S.. "Complete cytogenetic characterization of the human breast cancer cell line MA11 combining G-banding, comparative genomic hybridization, multicolor fluorescence in situ hybridization, RxFISH, and chromosome-specific painting". Cancer Genetics and Cytogenetics 131 1 (2001): 25-30. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035180787&partnerID=MN8TOARS.
  307. Teixeira, M.R.; Tsarouha, H.; Kraggerud, S.M.; Pandis, N.; Dimitriadis, E.; Andersen, J.A.; Lothe, R.A.; Heim, S.. "Evaluation of breast cancer polyclonality by combined chromosome banding and comparative genomic hybridization analysis". Neoplasia 3 3 (2001): 204-214. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034880470&partnerID=MN8TOARS.
  308. Panagopoulos, I.; Teixeira, M.R.; Micci, F.; Hammerstrsm, J.; Isaksson, M.; Johansson, B.; Mitelman, F.; Heim, S.. "Acute Myeloid Leukemia with inv(8)(p11q13)". Leukemia and Lymphoma 39 42130 (2000): 651-656. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034489925&partnerID=MN8TOARS.
  309. Teixeira, M.R.; Micci, F.; Dietrich, C.U.; Heim, S.. "Detailed genome-wide screening for inter- and intrachromosomal abnormalities by sequential G-banding and RxFISH color banding of the same metaphase cells". Cancer Genetics and Cytogenetics 119 2 (2000): 94-101. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034091604&partnerID=MN8TOARS.
  310. Kraggerud, S.M.; Szymanska, J.; Abeler, V.M.; Kærn, J.; Eknæs, M.; Heim, S.; Teixeira, M.R.; et al. "DNA copy number changes in malignant ovarian germ cell tumors". Cancer Research 60 11 (2000): 3025-3030. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034214053&partnerID=MN8TOARS.
  311. Teixeira, M.R.; Wæhre, H.; Lothe, R.A.; Stenwig, A.E.; Pandis, N.; Giercksky, K.E.; Heim, S.. "High frequency of clonal chromosome abnormalities in prostatic neoplasms sampled by prostatectomy or ultrasound-guided needle biopsy". Genes Chromosomes and Cancer 28 2 (2000): 211-219. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034059609&partnerID=MN8TOARS.
  312. Micci, F.; Teixeira, M.R.; Dietrich, C.U.; Sæter, G.; Bjerkehagen, B.; Heim, S.. "Combined RxFISH/G-banding allows refined karyotyping of solid tumors". Human Genetics 104 5 (1999): 370-375. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033040327&partnerID=MN8TOARS.
  313. Teixeira, M.R.; Micci, F.; Dietrich, C.U.; Heim, S.. "Cross-species color banding characterization of chromosomal rearrangements in leukemias with incomplete G-band karyotypes". Genes Chromosomes and Cancer 26 1 (1999): 13-19. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032839401&partnerID=MN8TOARS.
  314. Tsarouha, H.; Pandis, N.; Bardi, G.; Teixeira, M.R.; Andersen, J.A.; Heim, S.. "Karyotypic E evolution in breast carcinomas with i(1)(q10) and der(1;16)(q10;p10) as the primary chromosome abnormality". Cancer Genetics and Cytogenetics 113 2 (1999): 156-161. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032588199&partnerID=MN8TOARS.
  315. Teixeira, M.R.; Kristensen, G.B.; Abeler, V.M.; Heim, S.. "Karyotypic findings in tumors of the vulva and vagina". Cancer Genetics and Cytogenetics 111 1 (1999): 87-91. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032962932&partnerID=MN8TOARS.
  316. Teixeira, M.R.; Pandis, N.; Dietrich, C.U.; Reed, W.; Andersen, J.; Qvist, H.; Heim, S.. "Chromosome banding analysis of gynecomastias and breast carcinomas in men". Genes Chromosomes and Cancer 23 1 (1998): 16-20. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031880709&partnerID=MN8TOARS.
  317. Teixeira, M.R.; Qvist, H.; Bøhler, P.J.; Pandis, N.; Heim, S.. "Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin". Genes Chromosomes and Cancer 22 2 (1998): 145-151. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031979316&partnerID=MN8TOARS.
  318. Pandis, N.; Teixeira, M.R.; Adeyinka, A.; Rizou, H.; Bardi, G.; Mertens, F.; Andersen, J.A.; et al. "Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients". Genes Chromosomes and Cancer 22 2 (1998): 122-129. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031979315&partnerID=MN8TOARS.
  319. Teixeira, M.R.; Giercksky, K.E.; Ikonomou, I.M.; Heim, S.. "Translocation (3;3)(p14;q29) as the primary chromosome abnormality in a peritoneal mesothelioma". Cancer Genetics and Cytogenetics 103 1 (1998): 73-75. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032077363&partnerID=MN8TOARS.
  320. Teixeira, M.R.; Qvist, H.; Giercksky, K.E.; Bøhler, P.J.; Heim, S.. "Cytogenetic analysis of several pseudomyxoma peritonei lesions originating from a mucinous cystadenoma of the appendix". Cancer Genetics and Cytogenetics 93 2 (1997): 157-159. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030889238&partnerID=MN8TOARS.
  321. Heim, S.; Teixeira, M.R.; Dietrich, C.U.; Pandis, N.. "Cytogenetic polyclonality in tumors of the breast". Cancer Genetics and Cytogenetics 95 1 (1997): 16-19. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030988915&partnerID=MN8TOARS.
  322. Teixeira, M.R.; Pandis, N.; Bardi, G.; Andersen, J.A.; Bøhler, P.J.; Qvist, H.; Heim, S.. "Discrimination between multicentric and multifocal breast carcinoma by cytogenetic investigation of macroscopically distinct ipsilateral lesions". Genes Chromosomes and Cancer 18 3 (1997): 170-174. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030897156&partnerID=MN8TOARS.
  323. Gerdes, A.-M.; Pandis, N.; Bomme, L.; Dietrich, C.U.; Teixeira, M.R.; Bardi, G.; Heim, S.. "Fluorescence in situ hybridization of old G-banded and mounted chromosome preparations". Cancer Genetics and Cytogenetics 98 1 (1997): 9-15. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030768866&partnerID=MN8TOARS.
  324. Teixeira, M.R.; Pandis, N.; Gerdes, A.-M.; Dietrich, C.U.; Bardi, G.; Andersen, J.A.; Graversen, H.P.; Mitelman, F.; Heim, S.. "Cytogenetic abnormalities in an in situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer". Breast Cancer Research and Treatment 38 2 (1996): 177-182. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029998976&partnerID=MN8TOARS.
  325. Teixeira, M.R.; Pandis, N.; Bardi, G.; Andersen, J.A.; Heim, S.. "Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer". Cancer Research 56 4 (1996): 855-859. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030020692&partnerID=MN8TOARS.
  326. Cline, J.M.; Teixeira, M.R.; Heim, S.; Pandis, N.; Bardi, G.; Andersen, J.A.. "M. R. Teixeira et al., Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res., 56: 855-859, 1996". Cancer Research 56 21 (1996): http://www.scopus.com/inward/record.url?eid=2-s2.0-0029953487&partnerID=MN8TOARS.
  327. Dietrich, C.U.; Pandis, N.; Teixeira, M.R.; Bardi, G.; Gerdes, A.-M.; Andersen, J.A.; Heim, S.. "Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue". International Journal of Cancer 60 1 (1995): 49-53. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028966394&partnerID=MN8TOARS.
  328. Pandis, N.; Teixeira, M.R.; Gerdes, A.-M.; Limon, J.; Bardi, G.; Andersen, J.A.; Idvall, I.; et al. "Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors". Cancer 76 2 (1995): 250-258. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029042985&partnerID=MN8TOARS.
  329. Teixeira, M.R.; Pandis, N.; Bardi, G.; Andersen, J.A.; Mitelman, F.; Heim, S.. "Clonal heterogeneity in breast cancer: Karyotypic comparisons of multiple intra—and extra—tumorous samples from 3 patients". International Journal of Cancer 63 1 (1995): 63-68. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028848437&partnerID=MN8TOARS.
  330. Teixeira, M.R.; Pandis, N.; Bardi, G.; Andersen, J.A.; Mandahl, N.; Mitelman, F.; Heim, S.. "Cytogenetic analysis of multifocal breast carcinomas: Detection of karyotypically unrelated clones as well as clonal similarities between tumour foci". British Journal of Cancer 70 5 (1994): 922-927. http://www.scopus.com/inward/record.url?eid=2-s2.0-0027973945&partnerID=MN8TOARS.
  331. Dietrich, C.U.; Pandis, N.; Bardi, G.; Teixeira, M.R.; Soukhikh, T.; Petersson, C.; Andersen, J.A.; Heim, S.. "Karyotypic changes in phyllodes tumors of the breast". Cancer Genetics and Cytogenetics 78 2 (1994): 200-206. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028661210&partnerID=MN8TOARS.

Association member

Society Organization name Role
2013 - Current European Association for Cancer Research
2011 - 2013 Direction of Portuguese Society of Human Genetics (SPGH) - President 2012; Elected 2011; Outgoing 2013

Committee member

Activity description
Institution / Organization
2013 - 2017 Coordinator of the Scientific Committee of the Portuguese Society of Human Genetics (SPGH)


Activity description Institution / Organization
2008 - 2017 Visiting Professor, Center for Cancer Biomedicine, University of Oslo, Norway

Evaluation committee

Activity description
Institution / Organization Funding entity
2007 - 2018 External Quality Assessor, European Molecular Genetics Quality Network
2006 - 2012 External Quality Assessor, United Kingdom National External Quality Assessment Scheme in Clinical Cytogenetics


1997 Jacinto de Magalhães Medical Genetics Institute’s 1st prize (for the best Portuguese work in genetics)
Centro de Genética Médica Doutor Jacinto Magalhães, Portugal